Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AAK1 -0.38 0.3697 0.19 0.82591 PITA -0.12 0.00148 NA
2 hsa-miR-590-3p AASS -0.38 0.3697 -0.02 0.963 MirTarget; miRanda -0.24 0.0002 NA
3 hsa-miR-590-3p ABAT -0.38 0.3697 0.41 0.63594 PITA; miRanda -0.21 0.01796 NA
4 hsa-miR-590-3p ABCA1 -0.38 0.3697 -0.04 0.9599 miRanda -0.34 0 NA
5 hsa-miR-590-3p ABCA4 -0.38 0.3697 -0.59 0.40931 miRanda -0.24 0.04432 NA
6 hsa-miR-590-3p ABCA6 -0.38 0.3697 0.04 0.93252 MirTarget; miRanda -0.72 0 NA
7 hsa-miR-590-3p ABCA8 -0.38 0.3697 0.33 0.63462 miRanda -1.13 0 NA
8 hsa-miR-590-3p ABCA9 -0.38 0.3697 0.3 0.55978 miRanda -0.65 0 NA
9 hsa-miR-590-3p ABCB4 -0.38 0.3697 0.27 0.3986 miRanda -0.39 0 NA
10 hsa-miR-590-3p ABCC4 -0.38 0.3697 -0.02 0.977 mirMAP -0.19 0.0024 NA
11 hsa-miR-590-3p ABCC9 -0.38 0.3697 0.35 0.38195 miRanda; mirMAP -0.72 0 NA
12 hsa-miR-590-3p ABCD2 -0.38 0.3697 -0.25 0.61042 MirTarget; miRanda; mirMAP -0.32 0.00073 NA
13 hsa-miR-590-3p ABI3BP -0.38 0.3697 -0.25 0.62496 miRanda -0.67 0 NA
14 hsa-miR-590-3p ABL2 -0.38 0.3697 0.09 0.91468 PITA; mirMAP; miRNATAP -0.13 0 NA
15 hsa-miR-590-3p ACSL1 -0.38 0.3697 0.01 0.99211 miRanda -0.13 0.01819 NA
16 hsa-miR-590-3p ACSL4 -0.38 0.3697 0.25 0.81892 MirTarget; PITA; miRanda; mirMAP -0.12 0.00663 NA
17 hsa-miR-590-3p ACSS3 -0.38 0.3697 0.29 0.54736 miRanda -0.85 0 NA
18 hsa-miR-590-3p ACTC1 -0.38 0.3697 0.4 0.50371 miRanda -1.06 0 NA
19 hsa-miR-590-3p ACTG2 -0.38 0.3697 0.13 0.89705 miRanda -1.05 0 NA
20 hsa-miR-590-3p ACTN1 -0.38 0.3697 -0.19 0.89878 miRanda; miRNATAP -0.17 0 NA
21 hsa-miR-590-3p ACVR1 -0.38 0.3697 0.07 0.93125 miRanda -0.13 0 NA
22 hsa-miR-590-3p ADAM12 -0.38 0.3697 0.19 0.81883 mirMAP -0.72 0 NA
23 hsa-miR-590-3p ADAM19 -0.38 0.3697 -0.01 0.98753 miRanda -0.32 0 NA
24 hsa-miR-590-3p ADAM22 -0.38 0.3697 -0.02 0.95942 MirTarget; PITA; miRanda; mirMAP -0.28 0.00121 NA
25 hsa-miR-590-3p ADAM23 -0.38 0.3697 0.03 0.94421 miRanda -0.88 0 NA
26 hsa-miR-590-3p ADAM33 -0.38 0.3697 -0.07 0.89061 miRanda -0.88 0 NA
27 hsa-miR-590-3p ADAMTS1 -0.38 0.3697 0.1 0.89917 miRanda -0.42 0 NA
28 hsa-miR-590-3p ADAMTS14 -0.38 0.3697 -0 0.99391 miRanda -0.26 0 NA
29 hsa-miR-590-3p ADAMTS16 -0.38 0.3697 -0.29 0.58093 miRanda; mirMAP -0.93 0 NA
30 hsa-miR-590-3p ADAMTS18 -0.38 0.3697 0.32 0.61502 PITA; miRanda; miRNATAP -0.86 0 NA
31 hsa-miR-590-3p ADAMTS19 -0.38 0.3697 0.41 0.65434 PITA; miRanda; mirMAP; miRNATAP -0.39 0.00716 NA
32 hsa-miR-590-3p ADAMTS3 -0.38 0.3697 0.23 0.49453 miRanda; mirMAP -0.53 0 NA
33 hsa-miR-590-3p ADAMTS5 -0.38 0.3697 0.08 0.85753 PITA; miRanda; miRNATAP -0.34 0 NA
34 hsa-miR-590-3p ADAMTS6 -0.38 0.3697 0.35 0.26772 miRanda -0.4 0 NA
35 hsa-miR-590-3p ADAMTS8 -0.38 0.3697 -0.23 0.60879 miRanda -0.66 0 NA
36 hsa-miR-590-3p ADAMTS9 -0.38 0.3697 0.04 0.95007 miRanda -0.23 5.0E-5 NA
37 hsa-miR-590-3p ADAMTSL1 -0.38 0.3697 0.05 0.90541 miRanda; mirMAP -0.62 0 NA
38 hsa-miR-590-3p ADAMTSL3 -0.38 0.3697 0.27 0.56402 miRanda -1.03 0 NA
39 hsa-miR-590-3p ADARB1 -0.38 0.3697 -0.12 0.85953 miRanda; mirMAP -0.18 2.0E-5 NA
40 hsa-miR-590-3p ADCY2 -0.38 0.3697 0.27 0.53867 mirMAP -0.82 0 NA
41 hsa-miR-590-3p ADCYAP1 -0.38 0.3697 0.09 0.88518 MirTarget; PITA; miRanda; miRNATAP -1.04 0 NA
42 hsa-miR-590-3p ADH1A -0.38 0.3697 0.31 0.72476 miRanda -0.33 0.00577 NA
43 hsa-miR-590-3p ADH1B -0.38 0.3697 -0.1 0.89253 miRanda; mirMAP -0.93 0 NA
44 hsa-miR-590-3p ADIPOQ -0.38 0.3697 -0.8 0.47146 PITA; miRanda; mirMAP -1.02 0 NA
45 hsa-miR-590-3p ADRB2 -0.38 0.3697 0.17 0.67129 MirTarget; PITA; miRanda -0.48 0 NA
46 hsa-miR-590-3p AFAP1 -0.38 0.3697 -0.06 0.95682 PITA; miRanda; miRNATAP -0.21 0 NA
47 hsa-miR-590-3p AFF2 -0.38 0.3697 0.23 0.71237 PITA; miRanda; mirMAP; miRNATAP -0.29 0.00541 NA
48 hsa-miR-590-3p AFF3 -0.38 0.3697 -0.12 0.76924 PITA; miRanda; mirMAP; miRNATAP -0.63 0 NA
49 hsa-miR-590-3p AGTR1 -0.38 0.3697 0.22 0.75375 miRanda -1.24 0 NA
50 hsa-miR-590-3p AHNAK -0.38 0.3697 -0.12 0.93956 miRanda -0.21 8.0E-5 NA
51 hsa-miR-590-3p AK5 -0.38 0.3697 -0.04 0.95332 miRanda; mirMAP -0.54 0 NA
52 hsa-miR-590-3p AKAP11 -0.38 0.3697 0.43 0.6938 MirTarget; miRanda; miRNATAP -0.1 0.00354 NA
53 hsa-miR-590-3p AKAP12 -0.38 0.3697 -0.13 0.87455 miRanda; mirMAP -0.79 0 NA
54 hsa-miR-590-3p AKAP13 -0.38 0.3697 -0.18 0.88348 PITA; miRanda; mirMAP -0.12 0.00071 NA
55 hsa-miR-590-3p AKAP2 -0.38 0.3697 0.12 0.8767 mirMAP -0.35 0 NA
56 hsa-miR-590-3p AKAP6 -0.38 0.3697 -0.03 0.93563 MirTarget; PITA; miRanda; mirMAP -0.42 0 NA
57 hsa-miR-590-3p ALDH1A3 -0.38 0.3697 0.39 0.62184 miRanda; mirMAP -0.56 0 NA
58 hsa-miR-590-3p ALDH1L2 -0.38 0.3697 0.34 0.5345 MirTarget; miRanda; mirMAP -0.38 0 NA
59 hsa-miR-590-3p ALOX15B -0.38 0.3697 -0.1 0.84769 miRanda -0.31 0.01736 NA
60 hsa-miR-590-3p ALOX5AP -0.38 0.3697 0.21 0.74415 miRanda -0.32 0 NA
61 hsa-miR-590-3p ALPK3 -0.38 0.3697 0.28 0.69388 miRanda; mirMAP -0.36 0.00074 NA
62 hsa-miR-590-3p AMOTL1 -0.38 0.3697 0.16 0.82157 mirMAP -0.7 0 NA
63 hsa-miR-590-3p AMOTL2 -0.38 0.3697 0.01 0.99431 miRanda -0.17 2.0E-5 NA
64 hsa-miR-590-3p ANGPT1 -0.38 0.3697 0.17 0.62216 PITA; miRanda; mirMAP -0.61 0 NA
65 hsa-miR-590-3p ANGPT2 -0.38 0.3697 0.37 0.51447 miRanda -0.16 0.0007 NA
66 hsa-miR-590-3p ANGPTL1 -0.38 0.3697 0.24 0.70436 PITA; miRanda; mirMAP -1.27 0 NA
67 hsa-miR-590-3p ANK2 -0.38 0.3697 -0.09 0.8433 MirTarget; PITA; miRanda -0.86 0 NA
68 hsa-miR-590-3p ANKDD1A -0.38 0.3697 -0.26 0.29586 PITA; miRanda -0.12 0.00596 NA
69 hsa-miR-590-3p ANKH -0.38 0.3697 0.21 0.86724 mirMAP; miRNATAP -0.13 0.00249 NA
70 hsa-miR-590-3p ANKRD29 -0.38 0.3697 0.64 0.08037 mirMAP -0.34 0.00023 NA
71 hsa-miR-590-3p ANKRD44 -0.38 0.3697 -0.2 0.53854 miRanda -0.34 0 NA
72 hsa-miR-590-3p ANKRD50 -0.38 0.3697 0.03 0.97538 PITA; miRanda; mirMAP -0.22 0 NA
73 hsa-miR-590-3p ANKRD6 -0.38 0.3697 0.04 0.88501 miRanda; mirMAP -0.46 0 NA
74 hsa-miR-590-3p ANO1 -0.38 0.3697 -0.19 0.83268 miRanda -0.23 0.01468 NA
75 hsa-miR-590-3p ANO2 -0.38 0.3697 0.1 0.80944 miRanda -0.16 0.02281 NA
76 hsa-miR-590-3p ANO5 -0.38 0.3697 0.43 0.50378 miRanda; mirMAP -0.68 0 NA
77 hsa-miR-590-3p ANO6 -0.38 0.3697 -0.01 0.99596 MirTarget; miRanda; mirMAP -0.12 0.00254 NA
78 hsa-miR-590-3p ANTXR1 -0.38 0.3697 0.14 0.90557 miRanda; mirMAP -0.77 0 NA
79 hsa-miR-590-3p ANTXR2 -0.38 0.3697 -0.02 0.98905 PITA; miRanda; mirMAP; miRNATAP -0.12 0.01367 NA
80 hsa-miR-590-3p ANXA5 -0.38 0.3697 0.04 0.97894 miRanda; mirMAP; miRNATAP -0.14 0.00015 NA
81 hsa-miR-590-3p AOX1 -0.38 0.3697 -0.54 0.21342 miRanda -0.68 0 NA
82 hsa-miR-590-3p AP1S2 -0.38 0.3697 0.16 0.78001 miRanda; mirMAP -0.3 0 NA
83 hsa-miR-590-3p APBB1IP -0.38 0.3697 -0.26 0.59944 miRanda -0.34 7.0E-5 NA
84 hsa-miR-590-3p APC -0.38 0.3697 0.26 0.75493 PITA; miRanda; mirMAP; miRNATAP -0.1 0.00339 NA
85 hsa-miR-590-3p APCDD1L -0.38 0.3697 -0.03 0.96903 miRanda -0.8 0 NA
86 hsa-miR-590-3p APLF -0.38 0.3697 0.2 0.61853 miRanda -0.16 0.00762 NA
87 hsa-miR-590-3p APOE -0.38 0.3697 -0.08 0.94358 miRanda -0.49 1.0E-5 NA
88 hsa-miR-590-3p APOL4 -0.38 0.3697 -0.45 0.46184 miRanda; mirMAP -0.17 0.02568 NA
89 hsa-miR-590-3p AQP9 -0.38 0.3697 -0.15 0.8049 miRanda; mirMAP; miRNATAP -0.59 3.0E-5 NA
90 hsa-miR-590-3p AR -0.38 0.3697 -0.38 0.58507 mirMAP; miRNATAP -0.86 0 NA
91 hsa-miR-590-3p ARAP3 -0.38 0.3697 0.23 0.76972 mirMAP -0.2 0.00066 NA
92 hsa-miR-590-3p ARHGAP10 -0.38 0.3697 0.14 0.79923 miRanda -0.31 7.0E-5 NA
93 hsa-miR-590-3p ARHGAP15 -0.38 0.3697 -0.15 0.64917 miRanda; mirMAP -0.34 1.0E-5 NA
94 hsa-miR-590-3p ARHGAP23 -0.38 0.3697 0.05 0.9518 miRanda -0.32 0 NA
95 hsa-miR-590-3p ARHGAP24 -0.38 0.3697 -0.06 0.89635 miRanda; mirMAP -0.32 0 NA
96 hsa-miR-590-3p ARHGAP25 -0.38 0.3697 -0.09 0.86423 miRanda -0.28 2.0E-5 NA
97 hsa-miR-590-3p ARHGAP28 -0.38 0.3697 0.06 0.84302 mirMAP -0.43 0 NA
98 hsa-miR-590-3p ARHGAP29 -0.38 0.3697 0.11 0.87992 miRanda; mirMAP -0.19 0.00069 NA
99 hsa-miR-590-3p ARHGAP31 -0.38 0.3697 0.01 0.9893 miRanda; mirMAP; miRNATAP -0.39 0 NA
100 hsa-miR-590-3p ARHGEF15 -0.38 0.3697 0.02 0.96438 miRanda; mirMAP -0.37 0 NA
101 hsa-miR-590-3p ARHGEF6 -0.38 0.3697 0.04 0.94822 miRanda; mirMAP -0.37 0 NA
102 hsa-miR-590-3p ARL10 -0.38 0.3697 0.01 0.96883 mirMAP -0.54 0 NA
103 hsa-miR-590-3p ARL15 -0.38 0.3697 0.33 0.62789 miRanda; mirMAP -0.21 0 NA
104 hsa-miR-590-3p ARMC9 -0.38 0.3697 -0.01 0.99331 MirTarget; miRanda -0.23 0 NA
105 hsa-miR-590-3p ARMCX2 -0.38 0.3697 0.25 0.66496 miRanda -0.54 0 NA
106 hsa-miR-590-3p ARMCX3 -0.38 0.3697 0.24 0.82019 PITA; miRanda; mirMAP -0.18 0.00034 NA
107 hsa-miR-590-3p ARNT2 -0.38 0.3697 -0.28 0.615 PITA; miRanda; miRNATAP -0.46 0 NA
108 hsa-miR-590-3p ARRDC3 -0.38 0.3697 -0.04 0.96797 mirMAP -0.16 4.0E-5 NA
109 hsa-miR-590-3p ARSB -0.38 0.3697 -0.22 0.74571 PITA; miRanda; mirMAP; miRNATAP -0.2 0 NA
110 hsa-miR-590-3p ASAP1 -0.38 0.3697 0.29 0.75318 MirTarget; miRanda; mirMAP -0.17 6.0E-5 NA
111 hsa-miR-590-3p ASB5 -0.38 0.3697 -0.04 0.96689 miRanda; mirMAP -0.98 0 NA
112 hsa-miR-590-3p ASPA -0.38 0.3697 0.11 0.88022 miRanda; mirMAP -0.46 0 NA
113 hsa-miR-590-3p ASPN -0.38 0.3697 0.39 0.60647 miRanda -0.92 0 NA
114 hsa-miR-590-3p ASTN1 -0.38 0.3697 0.28 0.76516 mirMAP -0.84 0 NA
115 hsa-miR-590-3p ASXL3 -0.38 0.3697 0.38 0.50416 mirMAP -0.27 0.02947 NA
116 hsa-miR-590-3p ATL1 -0.38 0.3697 -0.03 0.94534 miRanda -0.3 0 NA
117 hsa-miR-590-3p ATP10A -0.38 0.3697 0.02 0.96935 PITA; miRanda -0.59 0 NA
118 hsa-miR-590-3p ATP10D -0.38 0.3697 0.24 0.73378 MirTarget; miRanda; mirMAP -0.22 1.0E-5 NA
119 hsa-miR-590-3p ATP1B2 -0.38 0.3697 0.3 0.42662 miRanda -0.58 0 NA
120 hsa-miR-590-3p ATP2B4 -0.38 0.3697 -0.01 0.98886 mirMAP -0.43 0 NA
121 hsa-miR-590-3p ATP6V0D2 -0.38 0.3697 0.07 0.84664 miRanda -0.35 0.00022 NA
122 hsa-miR-590-3p ATP6V1G2 -0.38 0.3697 0.07 0.87124 miRanda -0.4 0 NA
123 hsa-miR-590-3p ATP7A -0.38 0.3697 0.15 0.83508 miRanda; mirMAP -0.1 0.00161 NA
124 hsa-miR-590-3p ATP8B2 -0.38 0.3697 0 0.9954 MirTarget; PITA; miRanda; miRNATAP -0.49 0 NA
125 hsa-miR-590-3p ATP8B4 -0.38 0.3697 -0.24 0.34452 MirTarget; miRanda -0.28 0 NA
126 hsa-miR-590-3p ATP9A -0.38 0.3697 0.17 0.89865 miRanda; mirMAP -0.18 0.0042 NA
127 hsa-miR-590-3p ATRN -0.38 0.3697 -0.05 0.95849 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.2 3.0E-5 NA
128 hsa-miR-590-3p ATRNL1 -0.38 0.3697 0.29 0.66607 MirTarget; miRanda; mirMAP -0.95 0 NA
129 hsa-miR-590-3p ATRX -0.38 0.3697 0.09 0.9345 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.12 1.0E-5 NA
130 hsa-miR-590-3p ATXN1 -0.38 0.3697 0.04 0.96341 miRNAWalker2 validate; PITA; miRanda; mirMAP -0.18 0 NA
131 hsa-miR-590-3p AVPR1A -0.38 0.3697 -0.03 0.94867 miRanda -0.5 0 NA
132 hsa-miR-590-3p AXL -0.38 0.3697 -0.01 0.99099 miRanda -0.49 0 NA
133 hsa-miR-590-3p B3GALNT1 -0.38 0.3697 0.36 0.424 MirTarget; miRanda; mirMAP -0.39 0 NA
134 hsa-miR-590-3p B3GNT9 -0.38 0.3697 -0.29 0.62554 miRanda; miRNATAP -0.17 2.0E-5 NA
135 hsa-miR-590-3p BACE1 -0.38 0.3697 0.01 0.99371 miRanda; mirMAP -0.22 0 NA
136 hsa-miR-590-3p BAHCC1 -0.38 0.3697 -0.11 0.88104 miRanda -0.22 0.00188 NA
137 hsa-miR-590-3p BANK1 -0.38 0.3697 0.19 0.64007 miRanda; mirMAP -0.28 0.00352 NA
138 hsa-miR-590-3p BARX1 -0.38 0.3697 0.24 0.77459 miRanda -0.27 0.0432 NA
139 hsa-miR-590-3p BASP1 -0.38 0.3697 0.28 0.68206 miRanda -0.49 0 NA
140 hsa-miR-590-3p BBS10 -0.38 0.3697 0.23 0.706 miRanda -0.11 0.00559 NA
141 hsa-miR-590-3p BBS5 -0.38 0.3697 0.22 0.64852 PITA; miRanda; miRNATAP -0.15 0.0121 NA
142 hsa-miR-590-3p BBS9 -0.38 0.3697 0.1 0.85518 miRanda; mirMAP -0.13 0.0001 NA
143 hsa-miR-590-3p BCAT1 -0.38 0.3697 0.1 0.87618 mirMAP -0.46 0 NA
144 hsa-miR-590-3p BCHE -0.38 0.3697 0.25 0.6671 miRanda; mirMAP -1.02 0 NA
145 hsa-miR-590-3p BCL6 -0.38 0.3697 -0.14 0.85011 miRanda -0.17 0.00036 NA
146 hsa-miR-590-3p BDH2 -0.38 0.3697 0.02 0.983 miRanda -0.1 0.02982 NA
147 hsa-miR-590-3p BDNF -0.38 0.3697 0.32 0.31178 miRanda; mirMAP; miRNATAP -0.32 0 NA
148 hsa-miR-590-3p BEND4 -0.38 0.3697 -0.11 0.88946 MirTarget; miRanda; miRNATAP -0.32 0.00335 NA
149 hsa-miR-590-3p BEND6 -0.38 0.3697 0.16 0.71841 miRanda; mirMAP -0.69 0 NA
150 hsa-miR-590-3p BHLHB9 -0.38 0.3697 -0.11 0.7966 mirMAP -0.17 0.00102 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 340 1672 2.973e-49 1.383e-45
2 BIOLOGICAL ADHESION 247 1032 5.095e-48 1.185e-44
3 CARDIOVASCULAR SYSTEM DEVELOPMENT 202 788 7.348e-44 8.548e-41
4 CIRCULATORY SYSTEM DEVELOPMENT 202 788 7.348e-44 8.548e-41
5 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 289 1395 4.709e-43 4.382e-40
6 REGULATION OF CELL DIFFERENTIATION 299 1492 1.274e-41 9.883e-39
7 NEUROGENESIS 286 1402 3.066e-41 2.038e-38
8 VASCULATURE DEVELOPMENT 142 469 1.425e-39 8.288e-37
9 CELL DEVELOPMENT 278 1426 2.658e-36 1.374e-33
10 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 222 1021 4.406e-36 2.05e-33
11 TISSUE DEVELOPMENT 288 1518 2.004e-35 8.477e-33
12 BLOOD VESSEL MORPHOGENESIS 116 364 8.85e-35 3.432e-32
13 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 236 1142 1.042e-34 3.729e-32
14 LOCOMOTION 230 1114 9.637e-34 3.203e-31
15 REGULATION OF CELL DEVELOPMENT 186 836 1.56e-31 4.838e-29
16 POSITIVE REGULATION OF CELL DIFFERENTIATION 183 823 5.431e-31 1.579e-28
17 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 243 1275 5.081e-30 1.391e-27
18 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 170 750 7.615e-30 1.968e-27
19 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 203 983 9.462e-30 2.317e-27
20 CELL MOTILITY 181 835 3.302e-29 7.316e-27
21 LOCALIZATION OF CELL 181 835 3.302e-29 7.316e-27
22 REGULATION OF CELLULAR COMPONENT MOVEMENT 171 771 7.799e-29 1.649e-26
23 REGULATION OF NEURON DIFFERENTIATION 137 554 4.27e-28 8.638e-26
24 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 130 513 8.678e-28 1.683e-25
25 CELLULAR COMPONENT MORPHOGENESIS 182 900 1.496e-25 2.784e-23
26 NEURON DIFFERENTIATION 178 874 2.282e-25 4.084e-23
27 RESPONSE TO ENDOGENOUS STIMULUS 253 1450 2.959e-25 5.1e-23
28 ORGAN MORPHOGENESIS 173 841 3.538e-25 5.879e-23
29 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 188 957 8.289e-25 1.33e-22
30 HEART DEVELOPMENT 116 466 3.523e-24 5.465e-22
31 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 238 1360 6.44e-24 9.666e-22
32 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 164 801 1.152e-23 1.674e-21
33 CELL CELL ADHESION 136 608 2.028e-23 2.859e-21
34 ANGIOGENESIS 86 293 2.641e-23 3.614e-21
35 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 191 1008 2.92e-23 3.881e-21
36 REGULATION OF NEURON PROJECTION DEVELOPMENT 105 408 3.459e-23 4.471e-21
37 TISSUE MORPHOGENESIS 124 533 5.447e-23 6.85e-21
38 EXTRACELLULAR STRUCTURE ORGANIZATION 87 304 9.783e-23 1.198e-20
39 POSITIVE REGULATION OF LOCOMOTION 105 420 3.872e-22 4.62e-20
40 REGULATION OF CELL MORPHOGENESIS 125 552 4.398e-22 5.116e-20
41 POSITIVE REGULATION OF RESPONSE TO STIMULUS 301 1929 5.338e-22 6.058e-20
42 REGULATION OF CELL PROJECTION ORGANIZATION 125 558 1.179e-21 1.306e-19
43 REGULATION OF CELL PROLIFERATION 247 1496 3.046e-21 3.296e-19
44 POSITIVE REGULATION OF CELL DEVELOPMENT 111 472 4.483e-21 4.74e-19
45 CENTRAL NERVOUS SYSTEM DEVELOPMENT 167 872 6.852e-21 7.085e-19
46 SKELETAL SYSTEM DEVELOPMENT 108 455 7.302e-21 7.386e-19
47 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 265 1656 7.665e-21 7.588e-19
48 REGULATION OF TRANSPORT 282 1804 1.102e-20 1.068e-18
49 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 287 1848 1.23e-20 1.168e-18
50 REGULATION OF CELL ADHESION 133 629 1.303e-20 1.212e-18
51 SYNAPSE ORGANIZATION 54 145 2.441e-20 2.227e-18
52 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 104 437 3.202e-20 2.865e-18
53 TAXIS 108 464 3.582e-20 3.145e-18
54 REGULATION OF SYSTEM PROCESS 114 507 5.679e-20 4.894e-18
55 RESPONSE TO OXYGEN CONTAINING COMPOUND 229 1381 6.235e-20 5.275e-18
56 EPITHELIUM DEVELOPMENT 174 945 7.122e-20 5.917e-18
57 REGULATION OF PHOSPHORUS METABOLIC PROCESS 256 1618 1.866e-19 1.524e-17
58 CELL CELL SIGNALING 148 767 6.593e-19 5.289e-17
59 RESPONSE TO WOUNDING 119 563 1.564e-18 1.234e-16
60 NEURON DEVELOPMENT 136 687 1.991e-18 1.544e-16
61 NEURON PROJECTION DEVELOPMENT 116 545 2.461e-18 1.877e-16
62 NEGATIVE REGULATION OF CELL DIFFERENTIATION 125 609 2.526e-18 1.896e-16
63 SENSORY ORGAN DEVELOPMENT 108 493 4.243e-18 3.134e-16
64 NEGATIVE REGULATION OF CELL COMMUNICATION 200 1192 5.143e-18 3.739e-16
65 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 84 337 7.284e-18 5.135e-16
66 EMBRYO DEVELOPMENT 162 894 7.281e-18 5.135e-16
67 POSITIVE REGULATION OF NEURON DIFFERENTIATION 79 306 7.865e-18 5.462e-16
68 MESENCHYME DEVELOPMENT 59 190 1.122e-17 7.674e-16
69 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 149 799 1.236e-17 8.337e-16
70 MUSCLE STRUCTURE DEVELOPMENT 98 432 1.329e-17 8.831e-16
71 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 179 1036 1.772e-17 1.145e-15
72 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 179 1036 1.772e-17 1.145e-15
73 TUBE DEVELOPMENT 115 552 1.897e-17 1.209e-15
74 EMBRYONIC MORPHOGENESIS 113 539 2.242e-17 1.41e-15
75 UROGENITAL SYSTEM DEVELOPMENT 77 299 2.405e-17 1.492e-15
76 CIRCULATORY SYSTEM PROCESS 87 366 4.45e-17 2.724e-15
77 STEM CELL DIFFERENTIATION 58 190 5.141e-17 3.107e-15
78 NEURON PROJECTION MORPHOGENESIS 92 402 7.395e-17 4.411e-15
79 HEAD DEVELOPMENT 135 709 7.876e-17 4.639e-15
80 POSITIVE REGULATION OF CELL COMMUNICATION 237 1532 8.139e-17 4.734e-15
81 REGULATION OF RESPONSE TO WOUNDING 93 413 1.502e-16 8.63e-15
82 RESPONSE TO EXTERNAL STIMULUS 268 1821 3.896e-16 2.211e-14
83 RESPONSE TO GROWTH FACTOR 101 475 4.411e-16 2.473e-14
84 CELL PROJECTION ORGANIZATION 158 902 4.616e-16 2.557e-14
85 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 130 689 6.4e-16 3.504e-14
86 REGULATION OF EPITHELIAL CELL PROLIFERATION 72 285 7.896e-16 4.272e-14
87 SINGLE ORGANISM CELL ADHESION 98 459 9.217e-16 4.929e-14
88 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 63 232 1.29e-15 6.821e-14
89 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 49 153 1.636e-15 8.551e-14
90 REGULATION OF DEVELOPMENTAL GROWTH 72 289 1.735e-15 8.97e-14
91 REGULATION OF GROWTH 121 633 2.53e-15 1.294e-13
92 BEHAVIOR 105 516 2.636e-15 1.333e-13
93 MESENCHYMAL CELL DIFFERENTIATION 45 134 3.197e-15 1.599e-13
94 REGULATION OF ION TRANSPORT 115 592 3.931e-15 1.946e-13
95 POSITIVE REGULATION OF CELL PROLIFERATION 144 814 4.415e-15 2.162e-13
96 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 158 926 4.991e-15 2.419e-13
97 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 83 368 5.991e-15 2.874e-13
98 SYNAPSE ASSEMBLY 31 69 6.178e-15 2.933e-13
99 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 73 303 7.285e-15 3.424e-13
100 CELL ACTIVATION 111 568 7.851e-15 3.653e-13
101 RESPONSE TO ORGANIC CYCLIC COMPOUND 156 917 9.785e-15 4.508e-13
102 REGULATION OF MAPK CASCADE 123 660 1.037e-14 4.729e-13
103 POSITIVE REGULATION OF MOLECULAR FUNCTION 259 1791 1.135e-14 5.129e-13
104 POSITIVE REGULATION OF MAPK CASCADE 97 470 1.242e-14 5.556e-13
105 MORPHOGENESIS OF AN EPITHELIUM 87 400 1.265e-14 5.604e-13
106 REGULATION OF BLOOD CIRCULATION 71 295 1.806e-14 7.928e-13
107 REGULATION OF PROTEIN MODIFICATION PROCESS 249 1710 1.839e-14 7.998e-13
108 RESPONSE TO LIPID 150 888 6.018e-14 2.593e-12
109 WOUND HEALING 95 470 8.831e-14 3.77e-12
110 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 55 204 1.144e-13 4.84e-12
111 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 181 1152 1.344e-13 5.636e-12
112 GROWTH 86 410 1.573e-13 6.536e-12
113 SINGLE ORGANISM BEHAVIOR 82 384 2.116e-13 8.715e-12
114 EMBRYONIC ORGAN DEVELOPMENT 85 406 2.436e-13 9.943e-12
115 MUSCLE ORGAN DEVELOPMENT 66 277 2.503e-13 1.013e-11
116 RESPONSE TO HORMONE 148 893 4.232e-13 1.698e-11
117 REGULATION OF MEMBRANE POTENTIAL 75 343 6.524e-13 2.595e-11
118 NEGATIVE REGULATION OF LOCOMOTION 63 263 6.775e-13 2.671e-11
119 REGULATION OF ANATOMICAL STRUCTURE SIZE 93 472 7.689e-13 2.981e-11
120 INTRACELLULAR SIGNAL TRANSDUCTION 227 1572 7.635e-13 2.981e-11
121 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 145 876 8.21e-13 3.157e-11
122 REGULATION OF ACTIN FILAMENT BASED PROCESS 70 312 1.06e-12 4.029e-11
123 LEUKOCYTE MIGRATION 62 259 1.065e-12 4.029e-11
124 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 42 138 1.161e-12 4.357e-11
125 REGULATION OF AXONOGENESIS 47 168 1.633e-12 6.08e-11
126 NEGATIVE REGULATION OF CELL ADHESION 56 223 1.672e-12 6.175e-11
127 REGULATION OF SYNAPSE ORGANIZATION 37 113 2.177e-12 7.975e-11
128 POSITIVE REGULATION OF CATALYTIC ACTIVITY 219 1518 2.259e-12 8.211e-11
129 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 216 1492 2.319e-12 8.364e-11
130 CONNECTIVE TISSUE DEVELOPMENT 51 194 2.547e-12 9.117e-11
131 EYE DEVELOPMENT 71 326 3.291e-12 1.169e-10
132 IMMUNE SYSTEM PROCESS 270 1984 3.763e-12 1.326e-10
133 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 44 154 3.803e-12 1.33e-10
134 REGULATION OF EPITHELIAL CELL MIGRATION 46 166 4.064e-12 1.411e-10
135 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 63 274 4.661e-12 1.607e-10
136 ARTERY DEVELOPMENT 29 75 4.738e-12 1.621e-10
137 MORPHOGENESIS OF A BRANCHING STRUCTURE 46 167 5.119e-12 1.738e-10
138 CELL PART MORPHOGENESIS 112 633 5.544e-12 1.869e-10
139 TUBE MORPHOGENESIS 70 323 5.968e-12 1.998e-10
140 REGULATION OF CHEMOTAXIS 48 180 6.393e-12 2.125e-10
141 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 56 232 9.276e-12 3.061e-10
142 LEUKOCYTE ACTIVATION 82 414 1.345e-11 4.406e-10
143 RESPONSE TO NITROGEN COMPOUND 139 859 1.358e-11 4.417e-10
144 NEGATIVE REGULATION OF CELL PROLIFERATION 112 643 1.531e-11 4.948e-10
145 MUSCLE TISSUE DEVELOPMENT 62 275 1.675e-11 5.376e-10
146 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 171 1135 2.39e-11 7.617e-10
147 DEVELOPMENTAL GROWTH 70 333 2.625e-11 8.308e-10
148 REGULATION OF CELL GROWTH 78 391 2.957e-11 9.296e-10
149 EMBRYONIC ORGAN MORPHOGENESIS 62 279 3.194e-11 9.975e-10
150 REGULATION OF VASCULATURE DEVELOPMENT 55 233 3.593e-11 1.114e-09
151 FOREBRAIN DEVELOPMENT 73 357 3.858e-11 1.189e-09
152 CARTILAGE DEVELOPMENT 41 147 4.727e-11 1.443e-09
153 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 25 62 4.745e-11 1.443e-09
154 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 64 296 5.335e-11 1.612e-09
155 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 50 203 5.484e-11 1.646e-09
156 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 54 229 5.637e-11 1.681e-09
157 AMEBOIDAL TYPE CELL MIGRATION 42 154 6.04e-11 1.79e-09
158 POSITIVE REGULATION OF CELL ADHESION 75 376 7.142e-11 2.098e-09
159 REGULATION OF CELL SUBSTRATE ADHESION 45 173 7.17e-11 2.098e-09
160 RESPONSE TO ALCOHOL 73 362 7.581e-11 2.205e-09
161 NEURON PROJECTION GUIDANCE 50 205 8.002e-11 2.313e-09
162 REGULATION OF HYDROLASE ACTIVITY 191 1327 8.378e-11 2.406e-09
163 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 33 104 8.646e-11 2.468e-09
164 IMMUNE SYSTEM DEVELOPMENT 102 582 8.859e-11 2.503e-09
165 HEART MORPHOGENESIS 51 212 8.877e-11 2.503e-09
166 CARDIAC CHAMBER DEVELOPMENT 40 144 9.308e-11 2.593e-09
167 LYMPHOCYTE ACTIVATION 70 342 9.297e-11 2.593e-09
168 REGULATION OF CELL DEATH 207 1472 1.032e-10 2.858e-09
169 COLLAGEN FIBRIL ORGANIZATION 19 38 1.078e-10 2.968e-09
170 POSITIVE REGULATION OF TRANSPORT 145 936 1.223e-10 3.349e-09
171 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 98 554 1.232e-10 3.351e-09
172 MUSCLE SYSTEM PROCESS 61 282 1.476e-10 3.991e-09
173 REGULATION OF TRANSMEMBRANE TRANSPORT 81 426 1.484e-10 3.991e-09
174 POSITIVE REGULATION OF HYDROLASE ACTIVITY 141 905 1.499e-10 4.007e-09
175 NEGATIVE REGULATION OF CELL DEVELOPMENT 64 303 1.508e-10 4.009e-09
176 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 58 262 1.611e-10 4.259e-09
177 REGULATION OF ORGAN MORPHOGENESIS 55 242 1.679e-10 4.414e-09
178 NEGATIVE CHEMOTAXIS 19 39 1.922e-10 5.024e-09
179 RESPIRATORY SYSTEM DEVELOPMENT 48 197 1.976e-10 5.136e-09
180 CELLULAR RESPONSE TO NITROGEN COMPOUND 91 505 2.125e-10 5.493e-09
181 SECOND MESSENGER MEDIATED SIGNALING 42 160 2.246e-10 5.774e-09
182 SYSTEM PROCESS 240 1785 2.413e-10 6.169e-09
183 OSSIFICATION 56 251 2.429e-10 6.176e-09
184 REGULATION OF GTPASE ACTIVITY 112 673 2.658e-10 6.721e-09
185 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 32 103 3.061e-10 7.7e-09
186 SENSORY ORGAN MORPHOGENESIS 54 239 3.095e-10 7.742e-09
187 REGULATION OF INFLAMMATORY RESPONSE 62 294 3.119e-10 7.76e-09
188 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 25 67 3.427e-10 8.483e-09
189 BONE DEVELOPMENT 41 156 3.524e-10 8.63e-09
190 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 41 156 3.524e-10 8.63e-09
191 EPITHELIAL CELL DIFFERENTIATION 89 495 3.783e-10 9.216e-09
192 REGULATION OF WNT SIGNALING PATHWAY 64 310 4.081e-10 9.89e-09
193 REGULATION OF HEART CONTRACTION 51 221 4.347e-10 1.048e-08
194 EAR DEVELOPMENT 47 195 4.496e-10 1.078e-08
195 CELLULAR RESPONSE TO HORMONE STIMULUS 96 552 4.899e-10 1.169e-08
196 REGULATION OF IMMUNE SYSTEM PROCESS 196 1403 6.007e-10 1.426e-08
197 REGULATION OF SECRETION 114 699 6.312e-10 1.491e-08
198 POSITIVE REGULATION OF OSSIFICATION 28 84 6.385e-10 1.501e-08
199 MUSCLE CELL DIFFERENTIATION 53 237 6.688e-10 1.564e-08
200 SYNAPTIC SIGNALING 79 424 6.768e-10 1.574e-08
201 REGULATION OF KINASE ACTIVITY 123 776 8.079e-10 1.87e-08
202 DIGESTIVE SYSTEM DEVELOPMENT 39 148 8.672e-10 1.998e-08
203 REGULATION OF CELLULAR LOCALIZATION 181 1277 9.445e-10 2.165e-08
204 NEURAL CREST CELL DIFFERENTIATION 26 75 9.88e-10 2.254e-08
205 ARTERY MORPHOGENESIS 21 51 1.057e-09 2.398e-08
206 REGULATION OF BODY FLUID LEVELS 89 506 1.189e-09 2.685e-08
207 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 41 162 1.212e-09 2.725e-08
208 REGULATION OF ENDOTHELIAL CELL MIGRATION 33 114 1.261e-09 2.822e-08
209 CELLULAR RESPONSE TO ACID CHEMICAL 43 175 1.298e-09 2.89e-08
210 POSITIVE REGULATION OF CHEMOTAXIS 34 120 1.326e-09 2.939e-08
211 REGULATION OF CELL ACTIVATION 86 484 1.364e-09 3.008e-08
212 REGULATION OF BLOOD PRESSURE 42 169 1.391e-09 3.052e-08
213 REGULATION OF CYTOKINE PRODUCTION 96 563 1.429e-09 3.121e-08
214 PROTEIN PHOSPHORYLATION 142 944 1.475e-09 3.207e-08
215 REGULATION OF CALCIUM ION TRANSPORT 48 209 1.667e-09 3.608e-08
216 LEUKOCYTE DIFFERENTIATION 60 292 1.732e-09 3.732e-08
217 NEGATIVE REGULATION OF CELL ACTIVATION 40 158 1.905e-09 4.085e-08
218 MODULATION OF SYNAPTIC TRANSMISSION 61 301 2.231e-09 4.761e-08
219 REGULATION OF OSSIFICATION 43 178 2.275e-09 4.834e-08
220 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 87 498 2.569e-09 5.434e-08
221 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 41 166 2.65e-09 5.579e-08
222 NEGATIVE REGULATION OF WOUND HEALING 22 58 2.722e-09 5.706e-08
223 REGULATION OF METAL ION TRANSPORT 64 325 3.011e-09 6.282e-08
224 RESPONSE TO OXYGEN LEVELS 62 311 3.228e-09 6.706e-08
225 POSITIVE REGULATION OF CYTOKINE PRODUCTION 70 370 3.273e-09 6.768e-08
226 SECRETION 98 588 3.299e-09 6.792e-08
227 DENDRITE DEVELOPMENT 26 79 3.531e-09 7.206e-08
228 REGULATION OF SYNAPSE ASSEMBLY 26 79 3.531e-09 7.206e-08
229 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 47 207 3.642e-09 7.4e-08
230 SKELETAL SYSTEM MORPHOGENESIS 46 201 4.081e-09 8.255e-08
231 CELL CHEMOTAXIS 40 162 4.164e-09 8.352e-08
232 POSITIVE REGULATION OF RESPONSE TO WOUNDING 40 162 4.164e-09 8.352e-08
233 REGULATION OF MUSCLE SYSTEM PROCESS 45 195 4.554e-09 9.094e-08
234 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 57 278 4.774e-09 9.493e-08
235 RESPONSE TO STEROID HORMONE 86 497 5.072e-09 1e-07
236 LYMPHOCYTE DIFFERENTIATION 47 209 5.057e-09 1e-07
237 REGULATION OF WOUND HEALING 34 126 5.309e-09 1.042e-07
238 COGNITION 53 251 5.693e-09 1.113e-07
239 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 35 133 6.503e-09 1.266e-07
240 NEPHRON DEVELOPMENT 32 115 6.552e-09 1.27e-07
241 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 44 191 7.129e-09 1.376e-07
242 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 29 98 7.183e-09 1.381e-07
243 DENDRITE MORPHOGENESIS 18 42 7.651e-09 1.465e-07
244 CARDIAC CHAMBER MORPHOGENESIS 30 104 7.705e-09 1.469e-07
245 REPRODUCTIVE SYSTEM DEVELOPMENT 74 408 7.84e-09 1.489e-07
246 NEURON MIGRATION 31 110 8.063e-09 1.525e-07
247 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 33 122 8.312e-09 1.566e-07
248 RESPONSE TO ACID CHEMICAL 62 319 8.938e-09 1.677e-07
249 REGULATION OF MUSCLE CONTRACTION 37 147 9.024e-09 1.686e-07
250 CELLULAR RESPONSE TO LIPID 80 457 1.025e-08 1.907e-07
251 DIVALENT INORGANIC CATION HOMEOSTASIS 65 343 1.109e-08 2.055e-07
252 CARDIAC VENTRICLE DEVELOPMENT 30 106 1.255e-08 2.317e-07
253 REGULATION OF EXTENT OF CELL GROWTH 29 101 1.53e-08 2.813e-07
254 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 90 541 1.591e-08 2.904e-07
255 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 90 541 1.591e-08 2.904e-07
256 VASCULAR PROCESS IN CIRCULATORY SYSTEM 39 163 1.661e-08 3.02e-07
257 ENDOTHELIUM DEVELOPMENT 27 90 1.701e-08 3.079e-07
258 SECRETION BY CELL 83 486 1.736e-08 3.131e-07
259 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 29 102 1.952e-08 3.507e-07
260 GLOMERULUS DEVELOPMENT 19 49 2.148e-08 3.845e-07
261 GLAND DEVELOPMENT 71 395 2.3e-08 4.1e-07
262 REGULATION OF CELL CELL ADHESION 69 380 2.387e-08 4.239e-07
263 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 32 121 2.513e-08 4.447e-07
264 REGULATION OF CELL SIZE 40 172 2.566e-08 4.522e-07
265 NEGATIVE REGULATION OF PLATELET ACTIVATION 11 17 2.674e-08 4.696e-07
266 CARDIAC MUSCLE TISSUE DEVELOPMENT 35 140 2.715e-08 4.75e-07
267 MULTI MULTICELLULAR ORGANISM PROCESS 46 213 2.764e-08 4.817e-07
268 SPROUTING ANGIOGENESIS 18 45 2.84e-08 4.931e-07
269 CELL PROLIFERATION 105 672 3.098e-08 5.359e-07
270 POSITIVE REGULATION OF GENE EXPRESSION 224 1733 3.153e-08 5.434e-07
271 TELENCEPHALON DEVELOPMENT 48 228 3.246e-08 5.573e-07
272 REGULATION OF SMOOTH MUSCLE CONTRACTION 21 60 3.285e-08 5.62e-07
273 CRANIAL SKELETAL SYSTEM DEVELOPMENT 20 55 3.309e-08 5.64e-07
274 CELL GROWTH 34 135 3.507e-08 5.955e-07
275 AORTA DEVELOPMENT 17 41 3.64e-08 6.159e-07
276 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 49 236 3.723e-08 6.255e-07
277 NEGATIVE REGULATION OF GROWTH 49 236 3.723e-08 6.255e-07
278 NEGATIVE REGULATION OF CELL DEATH 128 872 4.257e-08 7.125e-07
279 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 231 1805 4.297e-08 7.165e-07
280 REGULATION OF COAGULATION 26 88 4.411e-08 7.33e-07
281 ACTION POTENTIAL 27 94 4.713e-08 7.805e-07
282 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 37 156 4.902e-08 8.089e-07
283 EAR MORPHOGENESIS 30 112 4.978e-08 8.185e-07
284 NEGATIVE REGULATION OF TRANSPORT 78 458 5.272e-08 8.637e-07
285 POSITIVE REGULATION OF KINASE ACTIVITY 81 482 5.318e-08 8.682e-07
286 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 127 867 5.439e-08 8.848e-07
287 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 17 42 5.595e-08 9.071e-07
288 NEGATIVE REGULATION OF CELL GROWTH 39 170 5.653e-08 9.134e-07
289 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 35 144 5.829e-08 9.385e-07
290 CELL SUBSTRATE ADHESION 38 164 6.299e-08 1.011e-06
291 REGULATION OF CELLULAR COMPONENT BIOGENESIS 115 767 6.787e-08 1.085e-06
292 REGULATION OF ORGAN GROWTH 23 73 7.02e-08 1.119e-06
293 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 16 38 7.082e-08 1.121e-06
294 LEUKOCYTE CELL CELL ADHESION 51 255 7.061e-08 1.121e-06
295 REGULATION OF CELL SHAPE 34 139 7.597e-08 1.198e-06
296 REGULATION OF HOMEOSTATIC PROCESS 76 447 8.372e-08 1.316e-06
297 REGULATION OF MESENCHYMAL CELL PROLIFERATION 15 34 8.553e-08 1.335e-06
298 PEPTIDYL TYROSINE MODIFICATION 41 186 8.527e-08 1.335e-06
299 REGULATION OF CARTILAGE DEVELOPMENT 21 63 8.684e-08 1.351e-06
300 CARDIAC SEPTUM DEVELOPMENT 25 85 8.804e-08 1.361e-06
301 PALATE DEVELOPMENT 25 85 8.804e-08 1.361e-06
302 NEGATIVE REGULATION OF COAGULATION 18 48 9.261e-08 1.427e-06
303 STRIATED MUSCLE CELL DIFFERENTIATION 39 173 9.306e-08 1.429e-06
304 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 19 53 9.489e-08 1.452e-06
305 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 78 465 1.013e-07 1.546e-06
306 REGULATION OF ION HOMEOSTASIS 43 201 1.031e-07 1.567e-06
307 INNER EAR MORPHOGENESIS 26 92 1.192e-07 1.806e-06
308 FORMATION OF PRIMARY GERM LAYER 29 110 1.205e-07 1.821e-06
309 VASCULOGENESIS 20 59 1.28e-07 1.928e-06
310 APPENDAGE DEVELOPMENT 38 169 1.453e-07 2.175e-06
311 LIMB DEVELOPMENT 38 169 1.453e-07 2.175e-06
312 WNT SIGNALING PATHWAY 63 351 1.485e-07 2.215e-06
313 INFLAMMATORY RESPONSE 76 454 1.605e-07 2.386e-06
314 MUSCLE CONTRACTION 47 233 1.743e-07 2.583e-06
315 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 32 131 1.879e-07 2.775e-06
316 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 18 50 1.914e-07 2.818e-06
317 CELL FATE COMMITMENT 46 227 2.042e-07 2.997e-06
318 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 225 1784 2.119e-07 3.101e-06
319 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 29 113 2.258e-07 3.294e-06
320 PATTERN SPECIFICATION PROCESS 71 418 2.306e-07 3.353e-06
321 ACTIN FILAMENT BASED PROCESS 75 450 2.315e-07 3.355e-06
322 ENDOTHELIAL CELL DIFFERENTIATION 22 72 2.466e-07 3.564e-06
323 RESPONSE TO ABIOTIC STIMULUS 142 1024 2.581e-07 3.718e-06
324 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 65 372 2.614e-07 3.755e-06
325 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 17 46 2.695e-07 3.858e-06
326 NEURAL CREST CELL MIGRATION 18 51 2.706e-07 3.862e-06
327 REGULATION OF EMBRYONIC DEVELOPMENT 29 114 2.767e-07 3.937e-06
328 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 24 84 2.891e-07 4.101e-06
329 REGULATION OF PROTEIN SECRETION 67 389 2.973e-07 4.205e-06
330 CALCIUM MEDIATED SIGNALING 25 90 2.986e-07 4.21e-06
331 CARDIOCYTE DIFFERENTIATION 26 96 3.011e-07 4.232e-06
332 CALCIUM ION TRANSPORT 45 223 3.127e-07 4.382e-06
333 CARDIAC VENTRICLE MORPHOGENESIS 20 62 3.225e-07 4.507e-06
334 BONE MORPHOGENESIS 23 79 3.505e-07 4.883e-06
335 CYCLIC NUCLEOTIDE METABOLIC PROCESS 19 57 3.554e-07 4.936e-06
336 REGULATED EXOCYTOSIS 45 224 3.572e-07 4.946e-06
337 CELLULAR CHEMICAL HOMEOSTASIS 89 570 3.619e-07 4.996e-06
338 REGULATION OF MUSCLE TISSUE DEVELOPMENT 27 103 3.684e-07 5.057e-06
339 REGULATION OF MUSCLE ORGAN DEVELOPMENT 27 103 3.684e-07 5.057e-06
340 REGULATION OF HEART GROWTH 16 42 3.72e-07 5.092e-06
341 GLAND MORPHOGENESIS 26 97 3.759e-07 5.116e-06
342 NERVE DEVELOPMENT 21 68 3.771e-07 5.116e-06
343 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 21 68 3.771e-07 5.116e-06
344 REGULATION OF CELLULAR COMPONENT SIZE 60 337 3.884e-07 5.253e-06
345 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 32 135 3.913e-07 5.277e-06
346 NEURON RECOGNITION 14 33 4.187e-07 5.631e-06
347 POSITIVE REGULATION OF AXONOGENESIS 21 69 4.957e-07 6.647e-06
348 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 29 117 5e-07 6.686e-06
349 DIGESTIVE TRACT MORPHOGENESIS 17 48 5.473e-07 7.297e-06
350 REGULATION OF PHOSPHOLIPASE ACTIVITY 20 64 5.749e-07 7.643e-06
351 POSITIVE REGULATION OF BLOOD CIRCULATION 25 93 5.901e-07 7.823e-06
352 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 33 144 5.941e-07 7.854e-06
353 LEARNING 31 131 6.147e-07 8.102e-06
354 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 138 1004 6.349e-07 8.345e-06
355 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 21 70 6.475e-07 8.487e-06
356 REGULATION OF MAP KINASE ACTIVITY 57 319 6.672e-07 8.72e-06
357 LEUKOCYTE PROLIFERATION 24 88 7.404e-07 9.623e-06
358 REGULATION OF STEM CELL PROLIFERATION 24 88 7.404e-07 9.623e-06
359 COCHLEA DEVELOPMENT 15 39 7.452e-07 9.659e-06
360 AMINOGLYCAN METABOLIC PROCESS 36 166 7.771e-07 1.004e-05
361 CHEMICAL HOMEOSTASIS 123 874 7.808e-07 1.006e-05
362 OVULATION CYCLE 28 113 7.874e-07 1.012e-05
363 OSTEOBLAST DIFFERENTIATION 30 126 8.075e-07 1.035e-05
364 RHYTHMIC PROCESS 54 298 8.3e-07 1.061e-05
365 AMINOGLYCAN BIOSYNTHETIC PROCESS 27 107 8.38e-07 1.068e-05
366 REGULATION OF RESPONSE TO STRESS 188 1468 8.578e-07 1.091e-05
367 DIVALENT INORGANIC CATION TRANSPORT 50 268 8.632e-07 1.094e-05
368 CYTOKINE PRODUCTION 29 120 8.815e-07 1.115e-05
369 DEVELOPMENTAL CELL GROWTH 22 77 8.947e-07 1.128e-05
370 LOCOMOTORY BEHAVIOR 38 181 9.139e-07 1.149e-05
371 PROTEOGLYCAN METABOLIC PROCESS 23 83 9.224e-07 1.157e-05
372 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 12 26 9.415e-07 1.178e-05
373 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 18 55 9.791e-07 1.219e-05
374 RESPONSE TO MECHANICAL STIMULUS 42 210 9.797e-07 1.219e-05
375 ION HOMEOSTASIS 88 576 1.08e-06 1.341e-05
376 MEMBRANE DEPOLARIZATION 19 61 1.16e-06 1.419e-05
377 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 19 61 1.16e-06 1.419e-05
378 TISSUE MIGRATION 23 84 1.161e-06 1.419e-05
379 REGULATION OF CELL MATRIX ADHESION 24 90 1.155e-06 1.419e-05
380 MUSCLE CELL DEVELOPMENT 30 128 1.152e-06 1.419e-05
381 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 107 740 1.162e-06 1.419e-05
382 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 40 197 1.178e-06 1.435e-05
383 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 39 190 1.2e-06 1.458e-05
384 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 35 162 1.208e-06 1.463e-05
385 ACTIVATION OF PROTEIN KINASE ACTIVITY 51 279 1.27e-06 1.535e-05
386 REGULATION OF PLATELET ACTIVATION 13 31 1.278e-06 1.541e-05
387 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 28 116 1.387e-06 1.668e-05
388 NEGATIVE REGULATION OF PHOSPHORYLATION 69 422 1.418e-06 1.701e-05
389 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 22 79 1.444e-06 1.723e-05
390 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 67 406 1.442e-06 1.723e-05
391 HEMOSTASIS 55 311 1.452e-06 1.727e-05
392 MULTICELLULAR ORGANISMAL SIGNALING 29 123 1.518e-06 1.797e-05
393 T CELL DIFFERENTIATION 29 123 1.518e-06 1.797e-05
394 POSITIVE REGULATION OF HEART GROWTH 12 27 1.554e-06 1.83e-05
395 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 12 27 1.554e-06 1.83e-05
396 REGULATION OF NEURON APOPTOTIC PROCESS 39 192 1.578e-06 1.855e-05
397 NEGATIVE REGULATION OF NEURON DEATH 36 171 1.635e-06 1.917e-05
398 CELLULAR HOMEOSTASIS 99 676 1.653e-06 1.932e-05
399 METAL ION TRANSPORT 88 582 1.676e-06 1.954e-05
400 REGULATION OF PROTEIN LOCALIZATION 130 950 1.715e-06 1.995e-05
401 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 22 80 1.821e-06 2.113e-05
402 ION TRANSPORT 164 1262 1.896e-06 2.195e-05
403 POSITIVE REGULATION OF GROWTH 45 238 2.059e-06 2.377e-05
404 KIDNEY EPITHELIUM DEVELOPMENT 29 125 2.153e-06 2.474e-05
405 REGULATION OF MUSCLE CELL DIFFERENTIATION 33 152 2.151e-06 2.474e-05
406 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 24 93 2.185e-06 2.492e-05
407 MULTICELLULAR ORGANISM METABOLIC PROCESS 24 93 2.185e-06 2.492e-05
408 REGULATION OF OSTEOBLAST DIFFERENTIATION 27 112 2.184e-06 2.492e-05
409 METANEPHROS DEVELOPMENT 22 81 2.286e-06 2.601e-05
410 PROTEOGLYCAN BIOSYNTHETIC PROCESS 18 58 2.342e-06 2.658e-05
411 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 66 404 2.46e-06 2.785e-05
412 NEURON CELL CELL ADHESION 9 16 2.768e-06 3.118e-05
413 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 9 16 2.768e-06 3.118e-05
414 MUSCLE ORGAN MORPHOGENESIS 20 70 2.777e-06 3.121e-05
415 RESPONSE TO KETONE 37 182 2.833e-06 3.177e-05
416 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 39 197 3.058e-06 3.421e-05
417 REGULATION OF RENAL SYSTEM PROCESS 14 38 3.188e-06 3.558e-05
418 MUCOPOLYSACCHARIDE METABOLIC PROCESS 26 108 3.439e-06 3.828e-05
419 VENTRICULAR SEPTUM DEVELOPMENT 17 54 3.573e-06 3.968e-05
420 REGULATION OF TRANSFERASE ACTIVITY 128 946 3.687e-06 4.085e-05
421 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 37 184 3.707e-06 4.097e-05
422 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 30 135 3.724e-06 4.106e-05
423 PLATELET ACTIVATION 31 142 3.828e-06 4.211e-05
424 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 12 29 3.898e-06 4.263e-05
425 POSITIVE REGULATION OF ION TRANSPORT 44 236 3.903e-06 4.263e-05
426 REGULATION OF CYTOKINE SECRETION 32 149 3.891e-06 4.263e-05
427 REGULATION OF ENDOCYTOSIS 39 199 3.95e-06 4.304e-05
428 CHONDROCYTE DIFFERENTIATION 18 60 4.032e-06 4.373e-05
429 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 18 60 4.032e-06 4.373e-05
430 CELL JUNCTION ORGANIZATION 37 185 4.232e-06 4.58e-05
431 MESODERM MORPHOGENESIS 19 66 4.331e-06 4.676e-05
432 CAMP METABOLIC PROCESS 13 34 4.426e-06 4.768e-05
433 NEGATIVE REGULATION OF SECRETION 39 200 4.481e-06 4.815e-05
434 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 14 39 4.557e-06 4.885e-05
435 REGULATION OF HOMOTYPIC CELL CELL ADHESION 53 307 4.664e-06 4.989e-05
436 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 40 208 4.85e-06 5.176e-05
437 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 73 470 4.863e-06 5.178e-05
438 POSITIVE REGULATION OF STEM CELL PROLIFERATION 18 61 5.234e-06 5.561e-05
439 CHONDROCYTE DEVELOPMENT 10 21 5.478e-06 5.806e-05
440 IMMUNE RESPONSE 144 1100 5.595e-06 5.916e-05
441 SMOOTH MUSCLE CONTRACTION 15 45 6.028e-06 6.346e-05
442 REGULATION OF JNK CASCADE 33 159 6.027e-06 6.346e-05
443 EPITHELIAL TO MESENCHYMAL TRANSITION 17 56 6.221e-06 6.52e-05
444 OUTFLOW TRACT MORPHOGENESIS 17 56 6.221e-06 6.52e-05
445 RESPONSE TO ESTROGEN 41 218 6.587e-06 6.888e-05
446 REGULATION OF IMMUNE RESPONSE 117 858 6.733e-06 7.024e-05
447 HOMEOSTATIC PROCESS 169 1337 6.948e-06 7.231e-05
448 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 40 211 6.962e-06 7.231e-05
449 CARDIAC MUSCLE CELL DIFFERENTIATION 20 74 7.074e-06 7.331e-05
450 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 17 57 8.115e-06 8.372e-05
451 ENDOTHELIAL CELL MIGRATION 17 57 8.115e-06 8.372e-05
452 REGULATION OF CHONDROCYTE DIFFERENTIATION 15 46 8.193e-06 8.434e-05
453 REGULATION OF PROTEIN IMPORT 36 183 8.374e-06 8.601e-05
454 RESPONSE TO CORTICOSTEROID 35 176 8.672e-06 8.888e-05
455 LUNG ALVEOLUS DEVELOPMENT 14 41 8.935e-06 9.137e-05
456 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 28 127 9.083e-06 9.268e-05
457 REGULATION OF SEQUESTERING OF CALCIUM ION 25 107 9.277e-06 9.383e-05
458 GASTRULATION 32 155 9.296e-06 9.383e-05
459 RESPONSE TO BMP 23 94 9.282e-06 9.383e-05
460 CELLULAR RESPONSE TO BMP STIMULUS 23 94 9.282e-06 9.383e-05
461 PLATELET DEGRANULATION 25 107 9.277e-06 9.383e-05
462 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 9 18 9.926e-06 9.911e-05
463 REGULATION OF COLLATERAL SPROUTING 9 18 9.926e-06 9.911e-05
464 POSITIVE REGULATION OF ENDOCYTOSIS 26 114 9.869e-06 9.911e-05
465 RETINAL GANGLION CELL AXON GUIDANCE 9 18 9.926e-06 9.911e-05
466 PHARYNGEAL SYSTEM DEVELOPMENT 9 18 9.926e-06 9.911e-05
467 POSITIVE REGULATION OF MAP KINASE ACTIVITY 39 207 1.048e-05 0.0001045
468 INTEGRIN MEDIATED SIGNALING PATHWAY 21 82 1.054e-05 0.0001048
469 REGULATION OF CALCIUM MEDIATED SIGNALING 20 76 1.096e-05 0.0001087
470 ION TRANSMEMBRANE TRANSPORT 112 822 1.099e-05 0.0001088
471 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 26 115 1.166e-05 0.0001152
472 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 16 53 1.256e-05 0.000123
473 NEURON PROJECTION EXTENSION 16 53 1.256e-05 0.000123
474 CYTOSOLIC CALCIUM ION TRANSPORT 16 53 1.256e-05 0.000123
475 EYE MORPHOGENESIS 29 136 1.255e-05 0.000123
476 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 25 109 1.309e-05 0.0001277
477 AXON EXTENSION 13 37 1.308e-05 0.0001277
478 EXOCYTOSIS 52 310 1.317e-05 0.0001282
479 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 20 77 1.354e-05 0.0001315
480 REGIONALIZATION 52 311 1.444e-05 0.00014
481 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 48 1.468e-05 0.000142
482 REGULATION OF CYTOSKELETON ORGANIZATION 75 502 1.479e-05 0.0001427
483 INNERVATION 10 23 1.497e-05 0.0001443
484 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 25 110 1.549e-05 0.0001489
485 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 21 84 1.574e-05 0.0001511
486 REGULATION OF INTERFERON GAMMA PRODUCTION 23 97 1.614e-05 0.0001542
487 LEUKOCYTE CHEMOTAXIS 26 117 1.614e-05 0.0001542
488 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 8 15 1.723e-05 0.0001642
489 KIDNEY VASCULATURE DEVELOPMENT 9 19 1.733e-05 0.0001645
490 RENAL SYSTEM VASCULATURE DEVELOPMENT 9 19 1.733e-05 0.0001645
491 REGULATION OF VASOCONSTRICTION 18 66 1.754e-05 0.0001659
492 LENS DEVELOPMENT IN CAMERA TYPE EYE 18 66 1.754e-05 0.0001659
493 ENSHEATHMENT OF NEURONS 22 91 1.768e-05 0.0001665
494 AXON ENSHEATHMENT 22 91 1.768e-05 0.0001665
495 REGULATION OF DEFENSE RESPONSE 104 759 1.782e-05 0.0001675
496 VENTRICULAR SEPTUM MORPHOGENESIS 11 28 1.794e-05 0.0001683
497 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 67 437 1.806e-05 0.0001691
498 POSITIVE REGULATION OF ORGAN GROWTH 13 38 1.823e-05 0.0001703
499 PHOSPHORYLATION 155 1228 1.833e-05 0.0001709
500 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 12 33 1.884e-05 0.000175
501 PALLIUM DEVELOPMENT 31 153 1.884e-05 0.000175
502 CATION TRANSPORT 108 796 1.891e-05 0.0001751
503 MESODERM DEVELOPMENT 26 118 1.893e-05 0.0001751
504 POSITIVE REGULATION OF CELL CELL ADHESION 43 243 1.926e-05 0.0001778
505 GLIOGENESIS 34 175 1.938e-05 0.0001779
506 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 15 49 1.938e-05 0.0001779
507 CARDIAC SEPTUM MORPHOGENESIS 15 49 1.938e-05 0.0001779
508 B CELL ACTIVATION 28 132 1.948e-05 0.0001784
509 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 86 602 2.049e-05 0.0001874
510 RESPONSE TO AMINO ACID 25 112 2.151e-05 0.0001962
511 REGULATION OF NEURON DEATH 44 252 2.181e-05 0.0001986
512 REGULATION OF SYNAPTIC PLASTICITY 29 140 2.24e-05 0.0002036
513 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 23 99 2.298e-05 0.0002076
514 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 23 99 2.298e-05 0.0002076
515 LIPID PHOSPHORYLATION 23 99 2.298e-05 0.0002076
516 REGULATION OF POSITIVE CHEMOTAXIS 10 24 2.357e-05 0.0002125
517 POSITIVE REGULATION OF CELL DEATH 86 605 2.469e-05 0.0002222
518 REGULATION OF PHOSPHOLIPASE C ACTIVITY 13 39 2.506e-05 0.0002247
519 REGULATION OF AXON GUIDANCE 13 39 2.506e-05 0.0002247
520 REGULATION OF ERK1 AND ERK2 CASCADE 42 238 2.561e-05 0.0002291
521 REGULATION OF DENDRITE DEVELOPMENT 26 120 2.584e-05 0.0002307
522 REGULATION OF DENDRITIC SPINE DEVELOPMENT 16 56 2.705e-05 0.0002412
523 ORGAN GROWTH 18 68 2.733e-05 0.0002431
524 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 7 12 2.77e-05 0.0002451
525 AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 12 2.77e-05 0.0002451
526 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 7 12 2.77e-05 0.0002451
527 AXONAL FASCICULATION 9 20 2.895e-05 0.0002556
528 IN UTERO EMBRYONIC DEVELOPMENT 51 311 2.971e-05 0.0002618
529 EXOCRINE SYSTEM DEVELOPMENT 14 45 2.982e-05 0.0002618
530 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 14 45 2.982e-05 0.0002618
531 ADULT BEHAVIOR 28 135 3.005e-05 0.0002631
532 NEGATIVE REGULATION OF IMMUNE RESPONSE 26 121 3.008e-05 0.0002631
533 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 38 209 3.1e-05 0.0002707
534 ANTERIOR POSTERIOR PATTERN SPECIFICATION 36 194 3.163e-05 0.0002756
535 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 19 75 3.229e-05 0.0002808
536 NEGATIVE REGULATION OF CHEMOTAXIS 15 51 3.292e-05 0.0002858
537 GLIAL CELL DIFFERENTIATION 28 136 3.459e-05 0.0002997
538 POSTSYNAPTIC MEMBRANE ORGANIZATION 10 25 3.606e-05 0.0003119
539 KIDNEY MORPHOGENESIS 20 82 3.66e-05 0.000316
540 RESPONSE TO MONOAMINE 12 35 3.727e-05 0.0003212
541 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 23 102 3.816e-05 0.0003282
542 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 11 30 3.842e-05 0.0003298
543 NEGATIVE REGULATION OF KINASE ACTIVITY 43 250 3.892e-05 0.0003335
544 CALCIUM ION TRANSMEMBRANE TRANSPORT 31 159 4.126e-05 0.0003529
545 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 18 70 4.17e-05 0.000356
546 REGULATION OF LIPASE ACTIVITY 20 83 4.413e-05 0.000376
547 NEGATIVE REGULATION OF CELL CELL ADHESION 28 138 4.556e-05 0.0003876
548 COCHLEA MORPHOGENESIS 9 21 4.655e-05 0.0003952
549 MESONEPHROS DEVELOPMENT 21 90 4.793e-05 0.0004062
550 T CELL PROLIFERATION 12 36 5.128e-05 0.000433
551 POSITIVE CHEMOTAXIS 12 36 5.128e-05 0.000433
552 NEGATIVE REGULATION OF AXONOGENESIS 17 65 5.357e-05 0.0004516
553 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 15 53 5.415e-05 0.0004557
554 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 8 17 5.504e-05 0.0004615
555 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 8 17 5.504e-05 0.0004615
556 POSITIVE REGULATION OF CELL ACTIVATION 50 311 5.974e-05 5e-04
557 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 13 42 6.067e-05 0.0005059
558 CALCIUM ION IMPORT INTO CYTOSOL 13 42 6.067e-05 0.0005059
559 ODONTOGENESIS 23 105 6.18e-05 0.0005144
560 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 30 155 6.275e-05 0.0005214
561 CELL MATRIX ADHESION 25 119 6.289e-05 0.0005216
562 POSITIVE REGULATION OF SECRETION 57 370 6.472e-05 0.0005359
563 TRANSMEMBRANE TRANSPORT 138 1098 6.512e-05 0.0005382
564 CELL RECOGNITION 29 148 6.55e-05 0.0005404
565 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 17 66 6.607e-05 0.0005416
566 RESPONSE TO PEPTIDE 61 404 6.611e-05 0.0005416
567 FOREBRAIN GENERATION OF NEURONS 17 66 6.607e-05 0.0005416
568 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 17 66 6.607e-05 0.0005416
569 DEFENSE RESPONSE 152 1231 6.766e-05 0.0005533
570 TRANSMISSION OF NERVE IMPULSE 15 54 6.87e-05 0.0005598
571 CARDIAC MUSCLE TISSUE MORPHOGENESIS 15 54 6.87e-05 0.0005598
572 CORONARY VASCULATURE DEVELOPMENT 12 37 6.961e-05 0.0005663
573 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 22 99 7.047e-05 0.0005723
574 NEGATIVE REGULATION OF MUSCLE CONTRACTION 9 22 7.239e-05 0.0005848
575 SOMATIC STEM CELL DIVISION 9 22 7.239e-05 0.0005848
576 AORTA MORPHOGENESIS 9 22 7.239e-05 0.0005848
577 REGULATION OF STEM CELL DIFFERENTIATION 24 113 7.286e-05 0.0005876
578 RESPONSE TO DRUG 64 431 7.328e-05 0.0005899
579 SALIVARY GLAND DEVELOPMENT 11 32 7.642e-05 0.0006141
580 CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 10 27 7.849e-05 0.0006253
581 NEGATIVE REGULATION OF AXON GUIDANCE 10 27 7.849e-05 0.0006253
582 REGULATION OF CATENIN IMPORT INTO NUCLEUS 10 27 7.849e-05 0.0006253
583 SUBSTRATE DEPENDENT CELL MIGRATION 10 27 7.849e-05 0.0006253
584 AXIS ELONGATION 10 27 7.849e-05 0.0006253
585 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 38 218 7.976e-05 0.0006344
586 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 85 616 7.995e-05 0.0006348
587 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 32 172 8.062e-05 0.0006391
588 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 17 67 8.107e-05 0.0006415
589 SEX DIFFERENTIATION 44 266 8.25e-05 0.0006517
590 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 22 100 8.265e-05 0.0006518
591 REGULATION OF ACUTE INFLAMMATORY RESPONSE 18 74 9.175e-05 0.0007224
592 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 12 38 9.333e-05 0.0007323
593 MESENCHYME MORPHOGENESIS 12 38 9.333e-05 0.0007323
594 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 17 68 9.899e-05 0.0007754
595 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 7 14 0.0001018 0.0007934
596 CAMP CATABOLIC PROCESS 7 14 0.0001018 0.0007934
597 POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY 7 14 0.0001018 0.0007934
598 FOREBRAIN CELL MIGRATION 16 62 0.0001048 0.0008155
599 EMBRYONIC EYE MORPHOGENESIS 11 33 0.0001052 0.0008172
600 OVULATION CYCLE PROCESS 20 88 0.0001064 0.0008239
601 REGULATION OF CATION CHANNEL ACTIVITY 20 88 0.0001064 0.0008239
602 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 14 50 0.0001084 0.0008349
603 REGULATION OF ADHERENS JUNCTION ORGANIZATION 14 50 0.0001084 0.0008349
604 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 15 56 0.0001083 0.0008349
605 CRANIAL NERVE MORPHOGENESIS 9 23 0.0001093 0.0008406
606 REGULATION OF ADAPTIVE IMMUNE RESPONSE 25 123 0.0001105 0.0008473
607 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 18 75 0.0001105 0.0008473
608 REGULATION OF TRANSPORTER ACTIVITY 35 198 0.0001125 0.0008601
609 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 22 102 0.0001128 0.0008601
610 RENAL SYSTEM PROCESS 22 102 0.0001128 0.0008601
611 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 17 69 0.0001203 0.000916
612 RESPONSE TO CYTOKINE 95 714 0.000123 0.0009352
613 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 12 39 0.0001237 0.0009372
614 LONG TERM SYNAPTIC POTENTIATION 12 39 0.0001237 0.0009372
615 INOSITOL LIPID MEDIATED SIGNALING 25 124 0.0001266 0.0009578
616 RESPONSE TO ESTRADIOL 28 146 0.0001279 0.0009664
617 REGENERATION 30 161 0.0001289 0.0009718
618 ENDOCHONDRAL BONE MORPHOGENESIS 13 45 0.0001338 0.001008
619 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 27 139 0.0001341 0.001008
620 PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 19 83 0.0001417 0.001064
621 FOREBRAIN NEURON DEVELOPMENT 11 34 0.0001427 0.00107
622 REGULATION OF LEUKOCYTE DIFFERENTIATION 39 232 0.0001439 0.001077
623 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 19 0.0001448 0.00108
624 ESTROUS CYCLE 8 19 0.0001448 0.00108
625 NEURAL PRECURSOR CELL PROLIFERATION 17 70 0.0001455 0.001083
626 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 46 289 0.0001469 0.001092
627 NEGATIVE REGULATION OF GENE EXPRESSION 177 1493 0.0001551 0.001151
628 STEM CELL DIVISION 10 29 0.0001572 0.001163
629 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 10 29 0.0001572 0.001163
630 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 9 24 0.0001607 0.001185
631 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 24 0.0001607 0.001185
632 EPITHELIAL CELL DEVELOPMENT 33 186 0.000162 0.001191
633 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 40 0.0001621 0.001191
634 CELLULAR RESPONSE TO PEPTIDE 44 274 0.0001652 0.001213
635 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 19 84 0.0001677 0.001229
636 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 13 46 0.0001711 0.001251
637 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 27 141 0.0001718 0.001255
638 REGULATION OF HEAT GENERATION 7 15 0.0001758 0.001278
639 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 7 15 0.0001758 0.001278
640 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 7 15 0.0001758 0.001278
641 CEREBRAL CORTEX DEVELOPMENT 22 105 0.0001762 0.001279
642 OLFACTORY BULB INTERNEURON DEVELOPMENT 6 11 0.0001788 0.001296
643 REGULATION OF VESICLE MEDIATED TRANSPORT 66 462 0.0001809 0.001309
644 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 18 78 0.0001886 0.001361
645 SOMITE DEVELOPMENT 18 78 0.0001886 0.001361
646 NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION 11 35 0.0001911 0.001374
647 REGULATION OF CHEMOKINE PRODUCTION 16 65 0.000191 0.001374
648 HEART PROCESS 19 85 0.0001977 0.001419
649 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 20 92 0.0002028 0.001454
650 CELLULAR RESPONSE TO CYTOKINE STIMULUS 82 606 0.0002033 0.001455
651 MYELOID LEUKOCYTE MIGRATION 21 99 0.0002045 0.001462
652 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 37 220 0.0002082 0.001486
653 REGULATION OF AMINE TRANSPORT 17 72 0.0002101 0.001489
654 REGULATION OF B CELL MEDIATED IMMUNITY 12 41 0.0002102 0.001489
655 CELL SUBSTRATE JUNCTION ASSEMBLY 12 41 0.0002102 0.001489
656 PROSTATE GLAND DEVELOPMENT 12 41 0.0002102 0.001489
657 RECEPTOR CLUSTERING 12 41 0.0002102 0.001489
658 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 14 53 0.000214 0.001511
659 CELLULAR RESPONSE TO AMINO ACID STIMULUS 14 53 0.000214 0.001511
660 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 83 616 0.0002143 0.001511
661 SMOOTH MUSCLE CELL DIFFERENTIATION 10 30 0.0002166 0.001518
662 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 10 30 0.0002166 0.001518
663 NEGATIVE REGULATION OF CELL MATRIX ADHESION 10 30 0.0002166 0.001518
664 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 10 30 0.0002166 0.001518
665 CELLULAR RESPONSE TO OXYGEN LEVELS 27 143 0.0002187 0.00153
666 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 8 20 0.0002221 0.001544
667 MIDDLE EAR MORPHOGENESIS 8 20 0.0002221 0.001544
668 MELANOCYTE DIFFERENTIATION 8 20 0.0002221 0.001544
669 REGULATION OF MONOCYTE CHEMOTAXIS 8 20 0.0002221 0.001544
670 MEMBRANE ASSEMBLY 9 25 0.0002309 0.001595
671 CELLULAR EXTRAVASATION 9 25 0.0002309 0.001595
672 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 25 0.0002309 0.001595
673 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 9 25 0.0002309 0.001595
674 POSITIVE REGULATION OF LIPASE ACTIVITY 16 66 0.000231 0.001595
675 REGULATION OF HEART RATE 19 86 0.0002323 0.001601
676 LIMBIC SYSTEM DEVELOPMENT 21 100 0.0002369 0.001631
677 CELL JUNCTION ASSEMBLY 25 129 0.0002424 0.001666
678 STEM CELL PROLIFERATION 15 60 0.00025 0.00171
679 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 15 60 0.00025 0.00171
680 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 15 60 0.00025 0.00171
681 RESPONSE TO EXTRACELLULAR STIMULUS 63 441 0.0002508 0.001714
682 NEUROMUSCULAR JUNCTION DEVELOPMENT 11 36 0.0002526 0.001716
683 REGULATION OF SENSORY PERCEPTION 11 36 0.0002526 0.001716
684 INORGANIC ION TRANSMEMBRANE TRANSPORT 79 583 0.000252 0.001716
685 REGULATION OF SENSORY PERCEPTION OF PAIN 11 36 0.0002526 0.001716
686 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 28 152 0.0002594 0.001759
687 HINDBRAIN DEVELOPMENT 26 137 0.0002606 0.001762
688 SKELETAL MUSCLE ORGAN DEVELOPMENT 26 137 0.0002606 0.001762
689 CELLULAR RESPONSE TO ALCOHOL 23 115 0.0002621 0.00177
690 REGULATION OF BONE REMODELING 12 42 0.0002701 0.001821
691 TISSUE REMODELING 19 87 0.0002721 0.001832
692 REGULATION OF INTERLEUKIN 2 PRODUCTION 13 48 0.0002728 0.001834
693 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 20 94 0.000275 0.001846
694 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 7 16 0.0002879 0.001922
695 EXTRACELLULAR MATRIX ASSEMBLY 7 16 0.0002879 0.001922
696 DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 7 16 0.0002879 0.001922
697 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 7 16 0.0002879 0.001922
698 PLACENTA DEVELOPMENT 26 138 0.0002936 0.001955
699 MATERNAL PLACENTA DEVELOPMENT 10 31 0.0002937 0.001955
700 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 17 74 0.0002982 0.001982
701 RESPONSE TO FIBROBLAST GROWTH FACTOR 23 116 0.0002991 0.001982
702 FEMALE SEX DIFFERENTIATION 23 116 0.0002991 0.001982
703 RETINA DEVELOPMENT IN CAMERA TYPE EYE 25 131 0.0003103 0.002054
704 REGULATION OF LIPID TRANSPORT 20 95 0.0003188 0.002107
705 REGULATION OF TYPE 2 IMMUNE RESPONSE 9 26 0.0003246 0.00213
706 REPLACEMENT OSSIFICATION 9 26 0.0003246 0.00213
707 VASODILATION 9 26 0.0003246 0.00213
708 ENDOCHONDRAL OSSIFICATION 9 26 0.0003246 0.00213
709 CELLULAR RESPONSE TO VITAMIN 9 26 0.0003246 0.00213
710 REGULATION OF KIDNEY DEVELOPMENT 14 55 0.0003257 0.002135
711 NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 6 12 0.00033 0.002145
712 NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 11 37 0.00033 0.002145
713 ROUNDABOUT SIGNALING PATHWAY 6 12 0.00033 0.002145
714 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 8 21 0.0003301 0.002145
715 LIPID TRANSLOCATION 8 21 0.0003301 0.002145
716 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 6 12 0.00033 0.002145
717 REGULATION OF CELL JUNCTION ASSEMBLY 16 68 0.0003331 0.002162
718 REGULATION OF RECEPTOR ACTIVITY 23 117 0.0003406 0.002207
719 CRANIAL NERVE DEVELOPMENT 12 43 0.0003437 0.002221
720 CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 12 43 0.0003437 0.002221
721 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 177 1517 0.0003465 0.002236
722 SENSORY PERCEPTION OF PAIN 17 75 0.0003533 0.002277
723 REGULATION OF CALCIUM ION IMPORT 21 103 0.0003627 0.002334
724 POSITIVE REGULATION OF CYTOKINE SECRETION 20 96 0.0003686 0.002369
725 POSITIVE REGULATION OF CELL GROWTH 27 148 0.0003887 0.002495
726 MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 10 32 0.0003924 0.002512
727 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 32 0.0003924 0.002512
728 PLASMA MEMBRANE ORGANIZATION 34 203 0.0003983 0.002546
729 REGULATION OF INTERLEUKIN 6 PRODUCTION 21 104 0.0004159 0.002655
730 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 13 50 0.0004221 0.00269
731 REGULATION OF GLIOGENESIS 19 90 0.0004292 0.002732
732 REGULATION OF LEUKOCYTE MIGRATION 27 149 0.0004342 0.002752
733 NEGATIVE REGULATION OF JAK STAT CASCADE 12 44 0.0004337 0.002752
734 NEGATIVE REGULATION OF STAT CASCADE 12 44 0.0004337 0.002752
735 REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 7 17 0.0004509 0.002835
736 REGULATION OF PLATELET AGGREGATION 7 17 0.0004509 0.002835
737 REGULATION OF PROTEIN KINASE A SIGNALING 7 17 0.0004509 0.002835
738 NEGATIVE REGULATION OF ANOIKIS 7 17 0.0004509 0.002835
739 PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 7 17 0.0004509 0.002835
740 COPULATION 7 17 0.0004509 0.002835
741 REGULATION OF HORMONE SECRETION 41 262 0.000468 0.002939
742 SIGNAL RELEASE 30 173 0.0004692 0.002942
743 NEGATIVE REGULATION OF ION TRANSPORT 24 127 0.0004707 0.002948
744 REGULATION OF HORMONE LEVELS 66 478 0.0004722 0.002953
745 POSITIVE REGULATION OF DEFENSE RESPONSE 53 364 0.0004745 0.002964
746 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 8 22 0.0004773 0.002973
747 SUBPALLIUM DEVELOPMENT 8 22 0.0004773 0.002973
748 MEMORY 20 98 0.0004889 0.003037
749 MYELOID LEUKOCYTE ACTIVATION 20 98 0.0004889 0.003037
750 ACTOMYOSIN STRUCTURE ORGANIZATION 17 77 0.00049 0.00304
751 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 25 135 0.0004979 0.003085
752 RESPONSE TO INORGANIC SUBSTANCE 66 479 0.0004999 0.003093
753 CYTOSKELETON ORGANIZATION 105 838 0.0005348 0.003304
754 SPINAL CORD DEVELOPMENT 21 106 0.0005432 0.00334
755 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 21 106 0.0005432 0.00334
756 REGULATION OF FAT CELL DIFFERENTIATION 21 106 0.0005432 0.00334
757 REPRODUCTION 153 1297 0.0005434 0.00334
758 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 222 1977 0.0005522 0.003389
759 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 16 71 0.0005584 0.003419
760 CELL FATE SPECIFICATION 16 71 0.0005584 0.003419
761 REGULATION OF CYTOPLASMIC TRANSPORT 66 481 0.0005598 0.003423
762 REGULATION OF VASCULOGENESIS 6 13 0.0005654 0.003439
763 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 6 13 0.0005654 0.003439
764 REGULATION OF CELL FATE SPECIFICATION 6 13 0.0005654 0.003439
765 DERMATAN SULFATE METABOLIC PROCESS 6 13 0.0005654 0.003439
766 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 30 175 0.000572 0.003474
767 RESPONSE TO NUTRIENT 32 191 0.0005775 0.003504
768 REGULATION OF JAK STAT CASCADE 26 144 0.0005812 0.003517
769 REGULATION OF STAT CASCADE 26 144 0.0005812 0.003517
770 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 14 58 0.000585 0.003535
771 POSITIVE REGULATION OF IMMUNE RESPONSE 75 563 0.0005906 0.003564
772 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 9 28 0.0006066 0.003642
773 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 9 28 0.0006066 0.003642
774 MUSCLE HYPERTROPHY 9 28 0.0006066 0.003642
775 NEURONAL ACTION POTENTIAL 9 28 0.0006066 0.003642
776 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 35 216 0.000619 0.003712
777 NEGATIVE REGULATION OF MOLECULAR FUNCTION 130 1079 0.0006212 0.00372
778 CELLULAR RESPONSE TO RETINOIC ACID 15 65 0.0006304 0.003761
779 CALCIUM ION IMPORT 15 65 0.0006304 0.003761
780 POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION 15 65 0.0006304 0.003761
781 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 13 52 0.0006355 0.003786
782 NEPHRON EPITHELIUM DEVELOPMENT 19 93 0.0006597 0.003925
783 PROSTATE GLAND MORPHOGENESIS 8 23 0.0006736 0.003982
784 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 10 34 0.0006734 0.003982
785 RESPONSE TO FLUID SHEAR STRESS 10 34 0.0006734 0.003982
786 REGULATION OF METANEPHROS DEVELOPMENT 8 23 0.0006736 0.003982
787 HEART VALVE DEVELOPMENT 10 34 0.0006734 0.003982
788 SMOOTH MUSCLE TISSUE DEVELOPMENT 7 18 0.0006798 0.004009
789 KIDNEY MESENCHYME DEVELOPMENT 7 18 0.0006798 0.004009
790 PROTEIN TRIMERIZATION 11 40 0.0006908 0.004064
791 ENDODERMAL CELL DIFFERENTIATION 11 40 0.0006908 0.004064
792 REGULATION OF INTRACELLULAR TRANSPORT 81 621 0.0006948 0.004082
793 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 14 59 0.0007034 0.004122
794 NEGATIVE REGULATION OF PROTEIN SECRETION 21 108 0.000703 0.004122
795 CAMERA TYPE EYE MORPHOGENESIS 20 101 0.0007329 0.004284
796 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 20 101 0.0007329 0.004284
797 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 24 131 0.0007488 0.004361
798 REGULATION OF CARDIAC MUSCLE CONTRACTION 15 66 0.0007479 0.004361
799 REGULATION OF CARDIAC CONDUCTION 15 66 0.0007479 0.004361
800 REGULATION OF IMMUNE EFFECTOR PROCESS 59 424 0.0007567 0.004401
801 MESONEPHRIC TUBULE MORPHOGENESIS 13 53 0.0007725 0.004488
802 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 9 29 0.0008088 0.004675
803 RESPONSE TO PAIN 9 29 0.0008088 0.004675
804 REGULATION OF EXCRETION 9 29 0.0008088 0.004675
805 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 9 29 0.0008088 0.004675
806 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 34 211 0.0008121 0.004688
807 SENSORY PERCEPTION OF MECHANICAL STIMULUS 27 155 0.0008181 0.004717
808 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 12 47 0.0008307 0.004784
809 CELL DEATH 121 1001 0.0008396 0.004829
810 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 47 321 0.0008528 0.004899
811 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 11 41 0.000867 0.004956
812 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 11 41 0.000867 0.004956
813 CANONICAL WNT SIGNALING PATHWAY 19 95 0.0008667 0.004956
814 POSITIVE REGULATION OF HEART CONTRACTION 10 35 0.0008663 0.004956
815 REGULATION OF NOTCH SIGNALING PATHWAY 15 67 0.0008834 0.005044
816 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 17 81 0.0009041 0.005136
817 REGULATION OF DENDRITE MORPHOGENESIS 16 74 0.0009029 0.005136
818 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 17 81 0.0009041 0.005136
819 REGULATION OF JUN KINASE ACTIVITY 17 81 0.0009041 0.005136
820 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 6 14 0.0009131 0.005138
821 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 14 0.0009131 0.005138
822 NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 6 14 0.0009131 0.005138
823 REGULATION OF GLOMERULUS DEVELOPMENT 6 14 0.0009131 0.005138
824 METANEPHRIC MESENCHYME DEVELOPMENT 6 14 0.0009131 0.005138
825 CONVERGENT EXTENSION 6 14 0.0009131 0.005138
826 CRANIOFACIAL SUTURE MORPHOGENESIS 6 14 0.0009131 0.005138
827 CELLULAR RESPONSE TO VITAMIN D 6 14 0.0009131 0.005138
828 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 31 188 0.0009158 0.005147
829 MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 29 172 0.0009198 0.005162
830 ALPHA BETA T CELL ACTIVATION 13 54 0.0009335 0.005233
831 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 34 213 0.0009616 0.005384
832 ENDOCYTOSIS 68 509 0.0009632 0.005387
833 REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 7 19 0.0009919 0.005501
834 THYMIC T CELL SELECTION 7 19 0.0009919 0.005501
835 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 7 19 0.0009919 0.005501
836 REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 7 19 0.0009919 0.005501
837 REGULATION OF LEUKOCYTE CHEMOTAXIS 19 96 0.0009897 0.005501
838 REACTIVE OXYGEN SPECIES METABOLIC PROCESS 19 96 0.0009897 0.005501
839 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 7 19 0.0009919 0.005501
840 RESPONSE TO AXON INJURY 12 48 0.001017 0.005605
841 REGULATION OF ENDOCRINE PROCESS 12 48 0.001017 0.005605
842 POSITIVE REGULATION OF WOUND HEALING 12 48 0.001017 0.005605
843 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 12 48 0.001017 0.005605
844 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 12 48 0.001017 0.005605
845 EPITHELIAL CELL PROLIFERATION 18 89 0.001023 0.005626
846 POST EMBRYONIC DEVELOPMENT 18 89 0.001023 0.005626
847 AGING 40 264 0.001036 0.005693
848 AMINOGLYCAN CATABOLIC PROCESS 15 68 0.001039 0.005702
849 CARDIAC CONDUCTION 17 82 0.001045 0.005721
850 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 17 82 0.001045 0.005721
851 MEMBRANE BIOGENESIS 9 30 0.001063 0.00579
852 CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 9 30 0.001063 0.00579
853 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 9 30 0.001063 0.00579
854 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 9 30 0.001063 0.00579
855 REGULATION OF LEUKOCYTE PROLIFERATION 33 206 0.001064 0.005793
856 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 11 42 0.001079 0.00583
857 CATECHOLAMINE METABOLIC PROCESS 11 42 0.001079 0.00583
858 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 11 42 0.001079 0.00583
859 EPITHELIAL CELL MORPHOGENESIS 11 42 0.001079 0.00583
860 CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 11 42 0.001079 0.00583
861 GENITALIA DEVELOPMENT 11 42 0.001079 0.00583
862 REGULATION OF NEUROTRANSMITTER LEVELS 31 190 0.001094 0.005908
863 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 10 36 0.001102 0.005909
864 NEGATIVE REGULATION OF BLOOD CIRCULATION 10 36 0.001102 0.005909
865 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 10 36 0.001102 0.005909
866 POSITIVE REGULATION OF AXON EXTENSION 10 36 0.001102 0.005909
867 OLFACTORY LOBE DEVELOPMENT 10 36 0.001102 0.005909
868 SEMAPHORIN PLEXIN SIGNALING PATHWAY 10 36 0.001102 0.005909
869 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 14 62 0.001186 0.006347
870 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 25 143 0.001187 0.006347
871 PROTEIN LOCALIZATION TO CELL PERIPHERY 26 151 0.001205 0.006437
872 RESPONSE TO ACTIVITY 15 69 0.001217 0.006496
873 EXTRACELLULAR MATRIX DISASSEMBLY 16 76 0.001221 0.00651
874 REGULATION OF NEURONAL SYNAPTIC PLASTICITY 12 49 0.001236 0.006558
875 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 12 49 0.001236 0.006558
876 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 12 49 0.001236 0.006558
877 CARDIAC CELL DEVELOPMENT 12 49 0.001236 0.006558
878 POSITIVE REGULATION OF COAGULATION 8 25 0.001259 0.006642
879 REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 8 25 0.001259 0.006642
880 DOPAMINE METABOLIC PROCESS 8 25 0.001259 0.006642
881 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 8 25 0.001259 0.006642
882 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 8 25 0.001259 0.006642
883 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 19 98 0.001281 0.006749
884 REGULATION OF CATECHOLAMINE SECRETION 11 43 0.001332 0.007009
885 OLFACTORY BULB INTERNEURON DIFFERENTIATION 6 15 0.001405 0.007207
886 OTIC VESICLE DEVELOPMENT 6 15 0.001405 0.007207
887 MATING 10 37 0.001388 0.007207
888 TONGUE DEVELOPMENT 7 20 0.001406 0.007207
889 INTERLEUKIN 1 PRODUCTION 6 15 0.001405 0.007207
890 REGULATION OF MEMBRANE LIPID DISTRIBUTION 10 37 0.001388 0.007207
891 REFLEX 7 20 0.001406 0.007207
892 NOSE DEVELOPMENT 6 15 0.001405 0.007207
893 REGULATION OF MESODERM DEVELOPMENT 6 15 0.001405 0.007207
894 MACROPHAGE ACTIVATION 9 31 0.001377 0.007207
895 PARTURITION 7 20 0.001406 0.007207
896 REGULATION OF REPRODUCTIVE PROCESS 23 129 0.001396 0.007207
897 BLASTODERM SEGMENTATION 6 15 0.001405 0.007207
898 CARDIAC MUSCLE CELL ACTION POTENTIAL 10 37 0.001388 0.007207
899 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 10 37 0.001388 0.007207
900 NEUROEPITHELIAL CELL DIFFERENTIATION 14 63 0.001399 0.007207
901 POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 9 31 0.001377 0.007207
902 POSITIVE REGULATION OF JUN KINASE ACTIVITY 14 63 0.001399 0.007207
903 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 10 37 0.001388 0.007207
904 LYMPH VESSEL DEVELOPMENT 7 20 0.001406 0.007207
905 VENOUS BLOOD VESSEL DEVELOPMENT 6 15 0.001405 0.007207
906 AMINO ACID IMPORT 6 15 0.001405 0.007207
907 POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 6 15 0.001405 0.007207
908 REGULATION OF CAMP METABOLIC PROCESS 23 129 0.001396 0.007207
909 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 31 193 0.001419 0.007263
910 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 25 145 0.001453 0.007428
911 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 26 153 0.001466 0.007486
912 ENDODERM FORMATION 12 50 0.001493 0.007617
913 REGULATION OF ANION TRANSPORT 24 138 0.001584 0.008073
914 CELLULAR RESPONSE TO INSULIN STIMULUS 25 146 0.001604 0.008163
915 POSITIVE REGULATION OF PROTEIN SECRETION 33 211 0.001605 0.008163
916 CELL CYCLE ARREST 26 154 0.001613 0.008195
917 BODY MORPHOGENESIS 11 44 0.001631 0.008239
918 POSITIVE REGULATION OF MUSCLE CONTRACTION 11 44 0.001631 0.008239
919 RENAL TUBULE DEVELOPMENT 16 78 0.00163 0.008239
920 NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 11 44 0.001631 0.008239
921 ENDOCRINE PROCESS 11 44 0.001631 0.008239
922 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 14 64 0.001643 0.008264
923 REGULATION OF NEUROTRANSMITTER TRANSPORT 14 64 0.001643 0.008264
924 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 19 100 0.001642 0.008264
925 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 19 100 0.001642 0.008264
926 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 8 26 0.001674 0.008395
927 MESODERMAL CELL DIFFERENTIATION 8 26 0.001674 0.008395
928 REGULATION OF CELL FATE COMMITMENT 8 26 0.001674 0.008395
929 REGULATION OF HEMOPOIESIS 45 314 0.001682 0.008426
930 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 101 829 0.001706 0.008536
931 NEGATIVE REGULATION OF AXON EXTENSION 10 38 0.001732 0.008637
932 ACTIN FILAMENT BASED MOVEMENT 18 93 0.001731 0.008637
933 BONE MINERALIZATION 10 38 0.001732 0.008637
934 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 9 32 0.001763 0.008753
935 REGULATION OF ORGAN FORMATION 9 32 0.001763 0.008753
936 PATTERNING OF BLOOD VESSELS 9 32 0.001763 0.008753
937 BLOOD VESSEL REMODELING 9 32 0.001763 0.008753
938 POSITIVE REGULATION OF HEMOPOIESIS 27 163 0.001769 0.008775
939 POSITIVE REGULATION OF LIPID TRANSPORT 12 51 0.001793 0.008864
940 REGULATION OF INTERLEUKIN 12 PRODUCTION 12 51 0.001793 0.008864
941 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 12 51 0.001793 0.008864
942 PROTEIN SECRETION 21 116 0.001813 0.008957
943 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 5 11 0.001835 0.009007
944 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 11 0.001835 0.009007
945 REGULATION OF FEVER GENERATION 5 11 0.001835 0.009007
946 ENTERIC NERVOUS SYSTEM DEVELOPMENT 5 11 0.001835 0.009007
947 POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 5 11 0.001835 0.009007
948 BASEMENT MEMBRANE ORGANIZATION 5 11 0.001835 0.009007
949 REGULATION OF PROTEIN TARGETING 44 307 0.001878 0.009207
950 CELLULAR RESPONSE TO EXTERNAL STIMULUS 39 264 0.001907 0.00934
951 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 28 172 0.001919 0.009388
952 DENDRITIC CELL MIGRATION 7 21 0.001945 0.009486
953 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 20 109 0.001949 0.009486
954 CELL DIFFERENTIATION IN HINDBRAIN 7 21 0.001945 0.009486
955 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 26 156 0.001947 0.009486
956 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 20 109 0.001949 0.009486
957 ALPHA BETA T CELL DIFFERENTIATION 11 45 0.001983 0.009621
958 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 11 45 0.001983 0.009621
959 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 11 45 0.001983 0.009621
960 DENDRITIC CELL CHEMOTAXIS 6 16 0.002075 0.009993
961 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 6 16 0.002075 0.009993
962 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 6 16 0.002075 0.009993
963 RESPONSE TO EPINEPHRINE 6 16 0.002075 0.009993
964 STRIATUM DEVELOPMENT 6 16 0.002075 0.009993
965 RESPONSE TO SALT 6 16 0.002075 0.009993
966 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 6 16 0.002075 0.009993
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 248 1476 2.178e-22 2.023e-19
2 GLYCOSAMINOGLYCAN BINDING 62 205 7.151e-18 3.322e-15
3 GROWTH FACTOR BINDING 45 123 7.769e-17 2.406e-14
4 HEPARIN BINDING 50 157 1.089e-15 2.522e-13
5 CALCIUM ION BINDING 130 697 1.629e-15 2.522e-13
6 CELL ADHESION MOLECULE BINDING 55 186 1.545e-15 2.522e-13
7 SULFUR COMPOUND BINDING 58 234 1.212e-12 1.608e-10
8 MOLECULAR FUNCTION REGULATOR 194 1353 8.159e-11 9.475e-09
9 INTEGRIN BINDING 33 105 1.151e-10 1.188e-08
10 CYTOSKELETAL PROTEIN BINDING 129 819 4.644e-10 4.314e-08
11 ACTIN BINDING 75 393 5.997e-10 5.065e-08
12 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 27 81 1.287e-09 9.351e-08
13 CYTOKINE BINDING 29 92 1.409e-09 9.351e-08
14 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 26 76 1.372e-09 9.351e-08
15 SIGNAL TRANSDUCER ACTIVITY 229 1731 2.882e-09 1.785e-07
16 RECEPTOR ACTIVITY 219 1649 4.833e-09 2.806e-07
17 PROTEIN COMPLEX BINDING 138 935 8.709e-09 4.759e-07
18 MACROMOLECULAR COMPLEX BINDING 188 1399 2.825e-08 1.458e-06
19 GATED CHANNEL ACTIVITY 61 325 4.482e-08 2.192e-06
20 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 164 1199 7.293e-08 3.388e-06
21 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 21 64 1.182e-07 5.228e-06
22 COLLAGEN BINDING 21 65 1.596e-07 6.74e-06
23 TRANSFORMING GROWTH FACTOR BETA BINDING 10 16 1.91e-07 7.715e-06
24 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 76 464 3.919e-07 1.517e-05
25 VOLTAGE GATED ION CHANNEL ACTIVITY 40 190 4.423e-07 1.644e-05
26 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 95 629 6.842e-07 2.445e-05
27 PROTEIN TYROSINE KINASE ACTIVITY 37 176 1.223e-06 4.206e-05
28 SIGNALING RECEPTOR ACTIVITY 179 1393 1.291e-06 4.284e-05
29 CHEMOREPELLENT ACTIVITY 12 27 1.554e-06 4.977e-05
30 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 57 328 1.673e-06 5.145e-05
31 ENZYME REGULATOR ACTIVITY 131 959 1.717e-06 5.145e-05
32 CATION CHANNEL ACTIVITY 53 298 1.879e-06 5.454e-05
33 GROWTH FACTOR ACTIVITY 34 160 2.527e-06 6.906e-05
34 FIBRONECTIN BINDING 12 28 2.493e-06 6.906e-05
35 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 11 25 4.821e-06 0.000128
36 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 52 303 6.803e-06 0.0001756
37 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 42 228 8.74e-06 0.0002194
38 CYCLIC NUCLEOTIDE BINDING 13 36 9.259e-06 0.0002205
39 G PROTEIN COUPLED RECEPTOR BINDING 46 259 9.093e-06 0.0002205
40 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 53 315 9.998e-06 0.0002322
41 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 19 70 1.114e-05 0.0002523
42 PLATELET DERIVED GROWTH FACTOR BINDING 7 11 1.254e-05 0.0002773
43 PROTEIN KINASE ACTIVITY 91 640 1.43e-05 0.0003091
44 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 22 90 1.465e-05 0.0003094
45 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 8 15 1.723e-05 0.0003556
46 PROTEIN DOMAIN SPECIFIC BINDING 88 624 2.693e-05 0.0005438
47 GLYCOPROTEIN BINDING 23 101 3.232e-05 0.0006388
48 ENZYME ACTIVATOR ACTIVITY 70 471 3.345e-05 0.0006474
49 INSULIN LIKE GROWTH FACTOR BINDING 10 25 3.606e-05 0.0006838
50 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 40 226 3.682e-05 0.0006841
51 PROTEOGLYCAN BINDING 11 30 3.842e-05 0.0006998
52 CYTOKINE RECEPTOR ACTIVITY 21 89 4.016e-05 0.0007176
53 KINASE ACTIVITY 111 842 5.009e-05 0.000878
54 BETA CATENIN BINDING 20 84 5.3e-05 0.0009117
55 METALLOENDOPEPTIDASE ACTIVITY 24 113 7.286e-05 0.001231
56 REGULATORY REGION NUCLEIC ACID BINDING 107 818 9.313e-05 0.001521
57 CORECEPTOR ACTIVITY 12 38 9.333e-05 0.001521
58 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 10 28 0.0001121 0.001796
59 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 51 329 0.0001308 0.00206
60 TRANSMEMBRANE TRANSPORTER ACTIVITY 125 997 0.0001591 0.002463
61 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 61 417 0.0001631 0.002484
62 HORMONE BINDING 16 65 0.000191 0.002817
63 RECEPTOR SIGNALING PROTEIN ACTIVITY 31 172 0.0001884 0.002817
64 GROWTH FACTOR RECEPTOR BINDING 25 129 0.0002424 0.003519
65 IDENTICAL PROTEIN BINDING 146 1209 0.0002629 0.003758
66 PROTEIN KINASE A BINDING 12 42 0.0002701 0.003801
67 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 7 16 0.0002879 0.003876
68 LIGAND GATED CALCIUM CHANNEL ACTIVITY 7 16 0.0002879 0.003876
69 CGMP BINDING 7 16 0.0002879 0.003876
70 WNT PROTEIN BINDING 10 31 0.0002937 0.003897
71 PROTEIN DIMERIZATION ACTIVITY 139 1149 0.0003414 0.004435
72 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 43 0.0003437 0.004435
73 PROTEIN HOMODIMERIZATION ACTIVITY 93 722 0.0004433 0.00544
74 CHEMOATTRACTANT ACTIVITY 9 27 0.0004476 0.00544
75 METALLOPEPTIDASE ACTIVITY 32 188 0.0004348 0.00544
76 TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY 7 17 0.0004509 0.00544
77 PDZ DOMAIN BINDING 19 90 0.0004292 0.00544
78 KINASE BINDING 80 606 0.0005209 0.006126
79 EXTRACELLULAR MATRIX BINDING 13 51 0.0005196 0.006126
80 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 128 0.00053 0.006155
81 INTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY 9 28 0.0006066 0.006957
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 129 426 5.263e-36 2.381e-33
2 PROTEINACEOUS EXTRACELLULAR MATRIX 116 356 8.154e-36 2.381e-33
3 INTRINSIC COMPONENT OF PLASMA MEMBRANE 281 1649 1.964e-26 3.823e-24
4 NEURON PROJECTION 189 942 4.33e-26 5.057e-24
5 CELL PROJECTION 297 1786 3.484e-26 5.057e-24
6 MEMBRANE REGION 214 1134 8.339e-26 8.116e-24
7 NEURON PART 229 1265 4.891e-25 4.081e-23
8 CELL JUNCTION 214 1151 6.255e-25 4.567e-23
9 EXTRACELLULAR MATRIX COMPONENT 53 125 4.349e-23 2.822e-21
10 SYNAPSE 155 754 1.387e-22 8.098e-21
11 CELL SURFACE 154 757 5.709e-22 3.031e-20
12 MEMBRANE MICRODOMAIN 76 288 8.714e-18 4.241e-16
13 SOMATODENDRITIC COMPARTMENT 128 650 3.285e-17 1.476e-15
14 POSTSYNAPSE 88 378 1.158e-16 4.832e-15
15 PLASMA MEMBRANE REGION 163 929 1.299e-16 5.058e-15
16 EXTRACELLULAR SPACE 216 1376 4.652e-16 1.698e-14
17 SYNAPSE PART 119 610 9.254e-16 3.179e-14
18 DENDRITE 94 451 1.718e-14 5.572e-13
19 BASEMENT MEMBRANE 34 93 4.684e-13 1.44e-11
20 SIDE OF MEMBRANE 87 428 7.186e-13 2.098e-11
21 CELL LEADING EDGE 75 350 1.891e-12 5.258e-11
22 COLLAGEN TRIMER 32 88 2.684e-12 7.126e-11
23 CELL CELL JUNCTION 79 383 3.816e-12 9.69e-11
24 AXON 83 418 8.802e-12 2.142e-10
25 PLASMA MEMBRANE PROTEIN COMPLEX 93 510 6.929e-11 1.619e-09
26 ANCHORING JUNCTION 90 489 8.532e-11 1.916e-09
27 CELL BODY 89 494 3.4e-10 7.355e-09
28 EXCITATORY SYNAPSE 47 197 6.47e-10 1.349e-08
29 RECEPTOR COMPLEX 65 327 1.528e-09 3.077e-08
30 CELL PROJECTION PART 141 946 3.12e-09 6.074e-08
31 SYNAPTIC MEMBRANE 54 261 8.679e-09 1.635e-07
32 COMPLEX OF COLLAGEN TRIMERS 13 23 1.429e-08 2.608e-07
33 SARCOLEMMA 33 125 1.602e-08 2.834e-07
34 EXTERNAL SIDE OF PLASMA MEMBRANE 50 238 1.816e-08 3.12e-07
35 POSTSYNAPTIC MEMBRANE 45 205 2.323e-08 3.877e-07
36 CELL SUBSTRATE JUNCTION 71 398 3.156e-08 5.12e-07
37 PLASMA MEMBRANE RAFT 25 86 1.134e-07 1.79e-06
38 CELL CELL ADHERENS JUNCTION 19 54 1.339e-07 2.058e-06
39 FILOPODIUM 26 94 1.91e-07 2.859e-06
40 FIBRIL 9 14 5.742e-07 8.383e-06
41 LAMELLIPODIUM 37 172 6.777e-07 9.653e-06
42 I BAND 29 121 1.059e-06 1.439e-05
43 INTRACELLULAR VESICLE 165 1259 1.049e-06 1.439e-05
44 CYTOPLASMIC SIDE OF MEMBRANE 35 170 3.864e-06 5.128e-05
45 EXTRINSIC COMPONENT OF MEMBRANE 46 252 4.298e-06 5.578e-05
46 ENDOPLASMIC RETICULUM LUMEN 39 201 5.077e-06 6.446e-05
47 CYTOPLASMIC VESICLE PART 88 601 6.26e-06 7.779e-05
48 CONTRACTILE FIBER 40 211 6.962e-06 8.47e-05
49 AXON PART 41 219 7.401e-06 8.82e-05
50 CELL PROJECTION MEMBRANE 51 298 8.996e-06 0.0001051
51 CELL CELL CONTACT ZONE 18 64 1.101e-05 0.0001261
52 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 29 136 1.255e-05 0.0001409
53 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 23 98 1.929e-05 0.0002125
54 LEADING EDGE MEMBRANE 28 134 2.606e-05 0.0002818
55 BANDED COLLAGEN FIBRIL 7 12 2.77e-05 0.0002928
56 RUFFLE 31 156 2.808e-05 0.0002928
57 SITE OF POLARIZED GROWTH 30 149 2.893e-05 0.0002964
58 NEURON SPINE 26 121 3.008e-05 0.0003029
59 PLATELET ALPHA GRANULE 19 75 3.229e-05 0.0003196
60 PERIKARYON 24 108 3.369e-05 0.0003279
61 ACTIN BASED CELL PROJECTION 34 181 4.004e-05 0.0003834
62 ACTIN CYTOSKELETON 66 444 5.513e-05 0.0005031
63 SECRETORY VESICLE 68 461 5.462e-05 0.0005031
64 NEURONAL POSTSYNAPTIC DENSITY 15 53 5.415e-05 0.0005031
65 PRESYNAPSE 46 283 8.861e-05 0.0007961
66 INTERSTITIAL MATRIX 7 14 0.0001018 0.0009008
67 ACTOMYOSIN 16 62 0.0001048 0.0009136
68 SECRETORY GRANULE 54 352 0.0001113 0.0009556
69 PLASMA MEMBRANE RECEPTOR COMPLEX 32 175 0.0001132 0.0009581
70 TRANSPORTER COMPLEX 50 321 0.0001343 0.001121
71 INTERCALATED DISC 14 51 0.0001369 0.001126
72 SECRETORY GRANULE LUMEN 19 85 0.0001977 0.001603
73 AXONAL GROWTH CONE 8 20 0.0002221 0.001776
74 NEURON PROJECTION TERMINUS 25 129 0.0002424 0.001898
75 CYTOPLASMIC REGION 45 287 0.0002438 0.001898
76 CATION CHANNEL COMPLEX 30 167 0.0002516 0.001934
77 RUFFLE MEMBRANE 18 80 0.0002643 0.001983
78 NEUROMUSCULAR JUNCTION 14 54 0.0002648 0.001983
79 PLATELET ALPHA GRANULE LUMEN 14 55 0.0003257 0.002408
80 GLYCOPROTEIN COMPLEX 8 21 0.0003301 0.002409
81 MEMBRANE PROTEIN COMPLEX 125 1020 0.0004051 0.002921
82 VESICLE LUMEN 21 106 0.0005432 0.003822
83 T TUBULE 12 45 0.0005428 0.003822
84 ENDOCYTIC VESICLE MEMBRANE 27 152 0.0005997 0.00417
85 VESICLE MEMBRANE 69 512 0.0007006 0.004813
86 VOLTAGE GATED SODIUM CHANNEL COMPLEX 6 14 0.0009131 0.006201
87 CELL CORTEX 37 238 0.0009745 0.006542
88 GOLGI APPARATUS 166 1445 0.001065 0.007071
89 APICAL PLASMA MEMBRANE 43 292 0.001232 0.008085

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Focal_adhesion_hsa04510 46 199 2.909e-09 9.647e-08
2 PI3K_Akt_signaling_pathway_hsa04151 67 352 5.498e-09 9.647e-08
3 Cell_adhesion_molecules_.CAMs._hsa04514 37 145 6.048e-09 9.647e-08
4 ECM_receptor_interaction_hsa04512 26 82 8.602e-09 9.647e-08
5 Rap1_signaling_pathway_hsa04015 46 206 9.276e-09 9.647e-08
6 Ras_signaling_pathway_hsa04014 47 232 1.525e-07 1.321e-06
7 Cytokine_cytokine_receptor_interaction_hsa04060 52 270 1.871e-07 1.39e-06
8 Calcium_signaling_pathway_hsa04020 39 182 3.802e-07 2.471e-06
9 cAMP_signaling_pathway_hsa04024 40 198 1.348e-06 7.303e-06
10 cGMP_PKG_signaling_pathway_hsa04022 35 163 1.404e-06 7.303e-06
11 Regulation_of_actin_cytoskeleton_hsa04810 39 208 1.178e-05 5.571e-05
12 MAPK_signaling_pathway_hsa04010 50 295 1.438e-05 5.818e-05
13 Apelin_signaling_pathway_hsa04371 29 137 1.455e-05 5.818e-05
14 Wnt_signaling_pathway_hsa04310 30 146 1.921e-05 6.738e-05
15 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 29 139 1.944e-05 6.738e-05
16 Hippo_signaling_pathway_hsa04390 31 154 2.156e-05 7.006e-05
17 Gap_junction_hsa04540 20 88 0.0001064 0.000311
18 Phagosome_hsa04145 29 152 0.0001077 0.000311
19 TGF_beta_signaling_pathway_hsa04350 19 84 0.0001677 0.0004588
20 Neuroactive_ligand_receptor_interaction_hsa04080 43 278 0.0004442 0.001155
21 Phospholipase_D_signaling_pathway_hsa04072 26 146 0.0007209 0.001785
22 Adherens_junction_hsa04520 14 72 0.005154 0.01218
23 Tight_junction_hsa04530 26 170 0.00637 0.0144
24 Hippo_signaling_pathway_multiple_species_hsa04392 7 29 0.01368 0.02963
25 FoxO_signaling_pathway_hsa04068 20 132 0.01691 0.03516
26 ABC_transporters_hsa02010 9 45 0.01899 0.03797
27 HIF_1_signaling_pathway_hsa04066 15 100 0.03806 0.07189
28 Jak_STAT_signaling_pathway_hsa04630 22 162 0.0392 0.07189
29 Sphingolipid_signaling_pathway_hsa04071 17 118 0.04009 0.07189
30 mTOR_signaling_pathway_hsa04150 20 151 0.05894 0.1022
31 NF_kappa_B_signaling_pathway_hsa04064 13 95 0.09183 0.154
32 Phosphatidylinositol_signaling_system_hsa04070 13 99 0.117 0.1902
33 Hedgehog_signaling_pathway_hsa04340 7 47 0.1338 0.2108
34 Ferroptosis_hsa04216 6 40 0.1544 0.2362
35 AMPK_signaling_pathway_hsa04152 14 121 0.2153 0.3199
36 Autophagy_animal_hsa04140 14 128 0.2807 0.4055
37 ErbB_signaling_pathway_hsa04012 9 85 0.3741 0.5257
38 Cellular_senescence_hsa04218 16 160 0.3922 0.5366
39 p53_signaling_pathway_hsa04115 7 68 0.4304 0.5739
40 VEGF_signaling_pathway_hsa04370 6 59 0.4564 0.5933
41 Endocytosis_hsa04144 23 244 0.4716 0.5981
42 TNF_signaling_pathway_hsa04668 10 108 0.5322 0.6589
43 Oocyte_meiosis_hsa04114 11 124 0.5879 0.711
44 Notch_signaling_pathway_hsa04330 4 48 0.6507 0.769
45 Lysosome_hsa04142 10 123 0.6978 0.8063
46 Autophagy_other_hsa04136 2 32 0.8041 0.9086
47 Apoptosis_hsa04210 10 138 0.8213 0.9086
48 Mitophagy_animal_hsa04137 3 65 0.9441 0.9973
49 Peroxisome_hsa04146 3 83 0.9848 0.9973
50 Necroptosis_hsa04217 8 164 0.9859 0.9973
51 Cell_cycle_hsa04110 4 124 0.9973 0.9973

Quest ID: 2cf5bbddc4ea44432edb3ac2672f3e99